<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Med (Lausanne)</journal-id><journal-id journal-id-type="iso-abbrev">Front Med (Lausanne)</journal-id><journal-id journal-id-type="pmc-domain-id">2657</journal-id><journal-id journal-id-type="pmc-domain">frontmedicine</journal-id><journal-id journal-id-type="publisher-id">Front. Med.</journal-id><journal-title-group><journal-title>Frontiers in Medicine</journal-title></journal-title-group><issn pub-type="epub">2296-858X</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11446853</article-id><article-id pub-id-type="pmcid-ver">PMC11446853.1</article-id><article-id pub-id-type="pmcaid">11446853</article-id><article-id pub-id-type="pmcaiid">11446853</article-id><article-id pub-id-type="pmid">39364022</article-id><article-id pub-id-type="doi">10.3389/fmed.2024.1449496</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Medicine</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Neurological and cardiopulmonary manifestations of pulmonary arteriovenous malformations</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lu</surname><given-names initials="W">Weida</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1708058/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dai</surname><given-names initials="H">Honggang</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2842343/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Y">Yunyi</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2642001/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Meng</surname><given-names initials="X">Xiao</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2011722/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Key Laboratory of Cardiovascular Proteomics of Shandong Province, Department of Geriatric Medicine, Qilu Hospital of Shandong University</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Department of Cardiology, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong University</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by" id="fn0001"><p>Edited by: Andy R. Eugene, Larned State Hospital, United States</p></fn><fn fn-type="edited-by" id="fn0002"><p>Reviewed by: Hui-Ting Li, Shanghai Pulmonary Hospital, China</p><p>Omer Topaloglu, Recep Tayyip Erdo&#287;an University, T&#252;rkiye</p></fn><corresp id="c001">*Correspondence: Xiao Meng, <email>mx81fly@163.com</email></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>11</volume><issue-id pub-id-type="pmc-issue-id">454139</issue-id><elocation-id>1449496</elocation-id><history><date date-type="received"><day>15</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>06</day><month>9</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>03</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-04 09:25:16.257"><day>04</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2024 Lu, Dai, Li and Meng.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Lu, Dai, Li and Meng</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fmed-11-1449496.pdf"/><abstract><p>Pulmonary arteriovenous malformations (PAVMs) are direct pulmonary artery-to-vein connections without pulmonary capillaries that result in intrapulmonary right-to-left blood shunts. Although most patients with PAVMs may be entirely asymptomatic, PAVMs can induce a series of complications involving the neurological, cardiovascular, and respiratory systems that can lead to catastrophic and often fatal clinical sequelae. In this study we review the available literature and summarize the reported PAVM-related complications among patients with PAVMs. The reviewed studies included observational studies, case studies, prospective studies, and cohort studies, and we provide an overview of PAVM-related neurological and cardiopulmonary manifestations, including stroke, cerebral abscess, transient ischemic attack, cerebral hemorrhage, migraine, seizure, dizziness, cardiac failure, arrhythmia, myocardial infarction, cough, hypoxemia, dyspnea, respiratory failure, hemoptysis, and hemothorax. Identifying and treating PAVMs before the presentation of major complication is important because this can prevent the occurrence of complications and can result in better outcomes. PAVM patients should thus be better evaluated and managed by a multidisciplinary team because they may be in a treatable phase prior to their condition becoming life-threatening.</p></abstract><kwd-group><kwd>pulmonary arteriovenous malformations</kwd><kwd>stroke</kwd><kwd>cerebral abscess</kwd><kwd>hypoxemia</kwd><kwd>treatment</kwd></kwd-group><funding-group><award-group><funding-source id="cn1"><institution-wrap><institution>National Natural Science Foundation of China</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id award-type="contract" rid="cn1">81970319</award-id></award-group><award-group><funding-source id="cn2">Taishan Scholars Program of Shandong Province</funding-source><award-id award-type="contract" rid="cn2">tsqn202103170</award-id></award-group><award-group><funding-source id="cn3">Program of Shandong Provincial Natural Science Foundation</funding-source><award-id award-type="contract" rid="cn3">ZR2023MH377</award-id></award-group></funding-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by the grants of the National Natural Science Foundation of China (No. 81970319 for XM), the Taishan Scholars Program of Shandong Province (No. tsqn202103170 for XM) and the Program of Shandong Provincial Natural Science Foundation (ZR2023MH377 for WL).</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="1"/><equation-count count="0"/><ref-count count="109"/><page-count count="13"/><word-count count="11568"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Pulmonary Medicine</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1"><label>1</label><title>Introduction</title><p>Pulmonary arteriovenous malformations (PAVMs) are rare pulmonary vascular malformations that were first reported in an autopsy study by Churton et al. (1987) in Saboo et al. (<xref rid="ref1" ref-type="bibr">1</xref>). PAVMs are estimated to affect approximately 1 in 2,600 individuals worldwide (<xref rid="ref2" ref-type="bibr">2</xref>, <xref rid="ref3" ref-type="bibr">3</xref>). PAVMs are often detected in adults, although the disease may develop during childhood (<xref rid="ref4" ref-type="bibr">4</xref>). Moreover, sex differences exist in the prevalence of PAVMs, occurring twice as often in females compared to males, but there is a male predominance in newborns (<xref rid="ref5" ref-type="bibr">5</xref>).</p><p>PAVMs are low-pressure and high-flow abnormal vascular structures that are characterized by a direct pulmonary artery-to-vein connection, thereby bypassing the normal pulmonary capillary bed (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref6" ref-type="bibr">6</xref>). These lesions can lead to an anatomic intrapulmonary right-to-left blood shunt because of the lack of a proper capillary network between the pulmonary arterial branch and the pulmonary venous tributary in the lungs, where blood bypasses the network that functions in gas exchange and filtration (<xref rid="fig1" ref-type="fig">Figure 1</xref>) (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref7" ref-type="bibr">7</xref>). Although PAVMs do not have malignant potential, they tend to increase in size over time because of pressure effects that gradually increase the intraluminal arterial blood flow (<xref rid="ref8" ref-type="bibr">8&#8211;10</xref>). Moreover, women older than 60&#8201;years tend to have larger PAVMs than younger women (<xref rid="ref3" ref-type="bibr">3</xref>).</p><fig position="float" id="fig1" orientation="portrait"><label>Figure 1</label><caption><p>The structure of the normal capillary bed and the PAVM.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmed-11-1449496-g001.jpg"/></fig></sec><sec id="sec2"><label>2</label><title>The etiology and classification of PAVMs</title><p>Although the etiology of PAVMs is not well understood, most PAVMs (80&#8211;90%) are congenital in nature and occur as either an isolated abnormality or as part of hereditary hemorrhagic telangiectasia (HHT) (<xref rid="ref1" ref-type="bibr">1</xref>). HHT, also named Rendu&#8211;Osler&#8211;Weber disease, is an autosomal-dominant familial disease with an estimated prevalence of 1 in 5,000, and it is most commonly caused by mutations in ENG, endoglin (HHT1), ACVLI/ALK1 (HHT2), or Smad4 (HTJP) (<xref rid="ref1" ref-type="bibr">1</xref>). Epistaxis, gastrointestinal bleeding, and visible mucocutaneous telangiectasia are the major clinical manifestations in HHT patients (<xref rid="ref11" ref-type="bibr">11&#8211;13</xref>). HHT can result in vascular malformations in many organs, including the lung, liver, and brain, particularly affecting the pulmonary vasculature and leading to PAVMs (<xref rid="ref7" ref-type="bibr">7</xref>). It is estimated that about 70% of patients with PAVMs eventually manifest with HHT (<xref rid="ref5" ref-type="bibr">5</xref>). HHT is considered to be the underlying cause of the PAVMs, which occur in 20&#8211;30% of the HHT population (<xref rid="ref14" ref-type="bibr">14</xref>, <xref rid="ref15" ref-type="bibr">15</xref>). Compared to isolated forms, HHT-associated PAVMs are always multiple, bilateral, and have a slight preference for the lung bases (<xref rid="ref1" ref-type="bibr">1</xref>). Moreover, HHT patients always have a rapid progression of PAVMs (<xref rid="ref16" ref-type="bibr">16</xref>). International guidelines recommend that PAVMs should be screened for in patients with possible or confirmed HHT (<xref rid="ref15" ref-type="bibr">15</xref>). Interestingly, there is a racial disparity in the presence of PAVMs among patients with HHT. Recently, a retrospective study showed that patients who identified as Asian have higher rates of PAVMs compared with patients who identified as white (<xref rid="ref17" ref-type="bibr">17</xref>). Therefore, the association between race and PAVM incidence may be important for identifying risk factors in certain patient populations.</p><p>PAVMs are classified as unilateral or bilateral, single or multiple, and simple or complex in occurrence on the basis of their distribution and angioarchitecture (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Most cases of PAVMs are multiple, and in one small-sample cross-sectional study including 75 patients with PAVMs, 49 patients (65.3%) had multiple PAVMs whereas 26 (34.7%) had single PAVMs (<xref rid="ref18" ref-type="bibr">18</xref>). In another relatively large cohort of 170 patients, 73 patients (42.9%) had single PAVMs, 49 (28.8%) had multiple PAVMs, 36 (21.2%) had disseminated PAVMs, and 12 (7.1%) had diffuse PAVMs (<xref rid="ref19" ref-type="bibr">19</xref>). Both solitary and multiple PAVMs are mostly located in the lower lobes of the lungs, with more presenting in the left lower lobe than in the right (<xref rid="ref6" ref-type="bibr">6</xref>). In addition, according to the number of feeding pulmonary arteries, PAVMs can be divided into two types: the simple form consists of a lesion with a single feeding artery and single draining vessel, and these make up the majority of lesions (80&#8211;90%), while the complex form is characterized by two or more afferent and efferent vessels and is rare (<xref rid="ref2" ref-type="bibr">2</xref>, <xref rid="ref19" ref-type="bibr">19</xref>, <xref rid="ref20" ref-type="bibr">20</xref>).</p><fig position="float" id="fig2" orientation="portrait"><label>Figure 2</label><caption><p>Cases of a simple and a complex PAVM before and after embolotherapy. <bold>(A,B)</bold> The simple PAVM was treated with Amplatzer Duct Occluder II (5&#8201;&#215;&#8201;4&#8201;mm). <bold>(C,D)</bold> The complex PAVM was treated with Amplatzer vascular plug (10&#8201;&#215;&#8201;7&#8201;mm) and Boston scientific interlock coils. (Black arrow, simple PAVM; asterisk, complex PAVMs; white arrowhead, embolotherapy material).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmed-11-1449496-g002.jpg"/></fig></sec><sec id="sec3"><label>3</label><title>The diagnosis of PAVMs</title><p>PAVMs are not easily or routinely diagnosed because of their rarity and their unspecific clinical manifestations. Chest X-ray, computed tomography (CT) and magnetic resonance are the main tools for diagnosing PAVMs. Among these diagnostic tools, CT can provide a better anatomical definition of both pulmonary parenchyma and vascularization and is generally considered the &#8220;gold standard&#8221; for diagnosing PAVM (<xref rid="fig3" ref-type="fig">Figure 3</xref>) (<xref rid="ref21" ref-type="bibr">21</xref>, <xref rid="ref22" ref-type="bibr">22</xref>). In one retrospective multicenter study, PAVMs were visible on CT scans in all patients, while only 54% of patients had visible PAVMs in chest X-ray images (<xref rid="ref23" ref-type="bibr">23</xref>). Compared to digital subtraction pulmonary arteriography, CT has a greater sensitivity (83% vs. 70%) in the detection of PAVMs, although the specificity is less (78% vs. 100%) (<xref rid="ref24" ref-type="bibr">24</xref>). Moreover, there are issues with the noninvasiveness of the procedure and the less radiation exposure when using CT. Transthoracic contrast echocardiography (TTCE) is a new diagnostic modality that has the ability to determine the grade of shunting and thus can predict the size of PAVMs and the subsequent feasibility for therapy. Among a cohort of 772 patients with possible or definite HHT, the positive predictive value of TTCE for the presence of PAVMs on chest CT was 13.4, 45.3, and 92.5% for pulmonary shunts of grade 1, 2, and 3, respectively (<xref rid="ref24" ref-type="bibr">24</xref>). Grade 1 shunting chest CT can be avoided following TTCE because the PAVMs may be too small to be treated by embolization (<xref rid="ref25" ref-type="bibr">25</xref>).</p><fig position="float" id="fig3" orientation="portrait"><label>Figure 3</label><caption><p>Typical CT appearance of a simple and a complex PAVM. <bold>(A)</bold> The simple PAVM. <bold>(B)</bold> The complex PAVMs. (White circle, aneurysmal sac).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmed-11-1449496-g003.jpg"/></fig></sec><sec id="sec4"><label>4</label><title>Comorbidities</title><p>From a clinical perspective, most patients with PAVMs may be entirely asymptomatic, especially with a single PAVM of less than 2&#8201;mm in diameter (<xref rid="ref14" ref-type="bibr">14</xref>). However, some patients may present with a variety of clinical manifestations such as chest pain, cough, dyspnea, palpitation, and hemoptysis when the diameter of the PAVM is more than 2&#8201;mm or the diameter of the feeding artery is greater than 3&#8201;mm (<xref rid="ref26" ref-type="bibr">26</xref>). The symptoms and signs of PAVMs mainly depend on the number, size, and shunt through the PAVM. Although some small PAVMs are silent, PAVMs may develop acute complications and lead to chronic disorders that result in adverse clinic outcome. A series of studies have shown that PAVM-associated complications are always multi-system and heterogeneous in their presentation, affecting the central nervous, cardiovascular, respiratory, and hematological systems. Importantly, PAVMs of any size are all associated with significant morbidity and mortality (<xref rid="ref27" ref-type="bibr">27</xref>), and there is evidence to suggest that 50% of patients with PAVMs will develop disabling or fatal complications if left untreated (<xref rid="ref28" ref-type="bibr">28</xref>). However, PAVMs are usually silent and are not noticed until further complications (<xref rid="ref1" ref-type="bibr">1</xref>). Therefore, prompt diagnosis and correct management is needed when there is clinical suspicion of PAVMs (<xref rid="ref22" ref-type="bibr">22</xref>). Preventing the progression of PAVMs and avoiding the risk of serious complications is a primary strategy for the treatment of PAVMs. In order to better understand this disease, we reviewed the available literature and summarized the reported PAVM-related complications.</p><sec id="sec5"><label>4.1</label><title>Neurological disorders</title><p>Patients with PAVMs have a higher risk of developing embolic complications due to the right-to-left shunt, and PAVM-associated neurological symptoms are common. It has been reported that 2.4&#8211;58.7% of PAVM patients develop a neurological manifestation, including stroke, cerebral abscess, transient ischemic attack (TIA), migraine, and hemorrhage (<xref rid="tab1" ref-type="table">Table 1</xref>) (<xref rid="ref18" ref-type="bibr">18</xref>, <xref rid="ref19" ref-type="bibr">19</xref>, <xref rid="ref23" ref-type="bibr">23</xref>, <xref rid="ref29" ref-type="bibr">29&#8211;46</xref>), which are attributed to hypoxemia and paradoxical embolisation (<xref rid="ref6" ref-type="bibr">6</xref>, <xref rid="ref10" ref-type="bibr">10</xref>, <xref rid="ref47" ref-type="bibr">47</xref>). Among them, ischemic strokes and brain abscesses affect greater numbers of individuals with PAVMs. In one retrospective cohort study including 219 patients diagnosed with PAVMs, 33.8% (<italic toggle="yes">n</italic>&#8201;=&#8201;74) of the patients had a stroke or brain abscess (<xref rid="ref29" ref-type="bibr">29</xref>). Importantly, many patients experienced ischemic stroke or brain abscess prior to the diagnosis of PAVMs (<xref rid="ref29" ref-type="bibr">29</xref>). Considering that neurological complications represent the main causes of morbidity in patients with PAVMs, recognizing which PAVM patients are at risk of neurological complications is critical to facilitating appropriate management strategies for the treatment of PAVMs.</p><table-wrap position="float" id="tab1" orientation="portrait"><label>Table 1</label><caption><p>Summary of the prevalence of neurological disorders in major PAVM series.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Study</th><th align="center" valign="top" rowspan="1" colspan="1"><italic toggle="yes">N</italic> (female)</th><th align="left" valign="top" rowspan="1" colspan="1">Manifestation</th><th align="center" valign="top" rowspan="1" colspan="1">Prevalence</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">2005, Post et al. (<xref rid="ref32" ref-type="bibr">32</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">208 (136)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke</td><td align="center" valign="top" rowspan="1" colspan="1">16.8% (35)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2005, Post et al. (<xref rid="ref32" ref-type="bibr">32</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">208 (136)</td><td align="left" valign="top" rowspan="1" colspan="1">TIA</td><td align="center" valign="top" rowspan="1" colspan="1">8.7% (18)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2020, Albitar et al. (<xref rid="ref41" ref-type="bibr">41</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">77 (46)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">11.7% (9)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2000, Moussouttas et al. (<xref rid="ref18" ref-type="bibr">18</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">75 (53)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke</td><td align="center" valign="top" rowspan="1" colspan="1">45.3% (34)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2013, Angriman et al. (<xref rid="ref42" ref-type="bibr">42</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">88</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">34.1% (30)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2018, Etievant et al. (<xref rid="ref19" ref-type="bibr">19</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">170 (92)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke</td><td align="center" valign="top" rowspan="1" colspan="1">16.5% (28)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2008, Shovlin et al. (<xref rid="ref29" ref-type="bibr">29</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">219 (140)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke</td><td align="center" valign="top" rowspan="1" colspan="1">13.7% (30)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2014, Shovlin et al. (<xref rid="ref30" ref-type="bibr">30</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">497 (302)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke</td><td align="center" valign="top" rowspan="1" colspan="1">12.3% (61)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2013, Velthuis et al. (<xref rid="ref39" ref-type="bibr">39</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">472</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">7.2% (34)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2007, Cottin et al. (<xref rid="ref23" ref-type="bibr">23</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">126 (79)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">15.9% (20)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2000, Faughnan et al. (<xref rid="ref43" ref-type="bibr">43</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">16 (10)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">50% (8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2001, Maher et al. (<xref rid="ref31" ref-type="bibr">31</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">71</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">29.6% (21)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2022, Na et al. (<xref rid="ref44" ref-type="bibr">44</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">55 (49)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">20% (11)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2015, Kim et al. (<xref rid="ref33" ref-type="bibr">33</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">90 (73)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke</td><td align="center" valign="top" rowspan="1" colspan="1">15.6% (14)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2004, Mager et al. (<xref rid="ref40" ref-type="bibr">40</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">112 (68)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">14% (15)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2006, Pollak et al. (<xref rid="ref34" ref-type="bibr">34</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">154 (90)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke</td><td align="center" valign="top" rowspan="1" colspan="1">32.5% (50)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2006, Pollak et al. (<xref rid="ref34" ref-type="bibr">34</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">154 (90)</td><td align="left" valign="top" rowspan="1" colspan="1">TIA</td><td align="center" valign="top" rowspan="1" colspan="1">22.7% (35)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2010, Shin et al. (<xref rid="ref35" ref-type="bibr">35</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">23 (21)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke</td><td align="center" valign="top" rowspan="1" colspan="1">4.3% (1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2008, Pierucci et al. (<xref rid="ref45" ref-type="bibr">45</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">36 (21)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">27.8% (10)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2021, Kroon et al. (<xref rid="ref46" ref-type="bibr">46</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">194 (108)</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">13% (25)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2018, Fatania et al. (<xref rid="ref36" ref-type="bibr">36</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">Stroke/TIA</td><td align="center" valign="top" rowspan="1" colspan="1">55.2% (17)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2018, Etievant et al. (<xref rid="ref19" ref-type="bibr">19</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">170 (92)</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebral abscess</td><td align="center" valign="top" rowspan="1" colspan="1">8.8% (15)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2008, Shovlin et al. (<xref rid="ref29" ref-type="bibr">29</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">219 (140)</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebral abscess</td><td align="center" valign="top" rowspan="1" colspan="1">12.8% (28)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2001, Maher et al. (<xref rid="ref31" ref-type="bibr">31</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">71</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebral abscess</td><td align="center" valign="top" rowspan="1" colspan="1">7.0% (5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2014, Kjeldsen et al. (<xref rid="ref37" ref-type="bibr">37</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">117</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebral abscess</td><td align="center" valign="top" rowspan="1" colspan="1">7.8% (9)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2017, Boother et al. (<xref rid="ref38" ref-type="bibr">38</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">445</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebral abscess</td><td align="center" valign="top" rowspan="1" colspan="1">8.3% (37)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2000, Moussouttas et al. (<xref rid="ref18" ref-type="bibr">18</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebral abscess</td><td align="center" valign="top" rowspan="1" colspan="1">13.3% (10)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2005, Post et al. (<xref rid="ref32" ref-type="bibr">32</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">538</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebral abscess</td><td align="center" valign="top" rowspan="1" colspan="1">3.5% (19)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2007, Cottin et al. (<xref rid="ref23" ref-type="bibr">23</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">126</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebral abscess</td><td align="center" valign="top" rowspan="1" colspan="1">19% (24)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2005, Post et al. (<xref rid="ref32" ref-type="bibr">32</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">538</td><td align="left" valign="top" rowspan="1" colspan="1">Migraine</td><td align="center" valign="top" rowspan="1" colspan="1">16.4% (88)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2000, Moussouttas et al. (<xref rid="ref18" ref-type="bibr">18</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="left" valign="top" rowspan="1" colspan="1">Migraine</td><td align="center" valign="top" rowspan="1" colspan="1">58.7% (44)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2001, Maher et al. (<xref rid="ref31" ref-type="bibr">31</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">71</td><td align="left" valign="top" rowspan="1" colspan="1">Migraine</td><td align="center" valign="top" rowspan="1" colspan="1">25.4% (18)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2000, Moussouttas et al. (<xref rid="ref18" ref-type="bibr">18</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="left" valign="top" rowspan="1" colspan="1">Seizure</td><td align="center" valign="top" rowspan="1" colspan="1">14.7% (11)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2007, Cottin et al. (<xref rid="ref23" ref-type="bibr">23</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">126</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebral hemorrhage</td><td align="center" valign="top" rowspan="1" colspan="1">2.4% (3)</td></tr></tbody></table></table-wrap><sec id="sec6"><label>4.1.1</label><title>Stroke</title><p>The brain is the most susceptible organ to circulatory abnormalities, and stroke can have serious and disastrous consequences. Patients with PAVMs are at increased risk for developing ischemic stroke, and stroke is by far the most common neurological complication of PAVMs because of paradoxical embolism (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref48" ref-type="bibr">48</xref>). These paradoxical microemboli unfiltered by the pulmonary capillary network enter the cerebral circulation through the right-to-left shunt, and can result the occlusion of cerebral arteries, which has been widely accepted as a potential cause of acute ischemic stroke (<xref rid="ref48" ref-type="bibr">48</xref>, <xref rid="ref49" ref-type="bibr">49</xref>). PAVMs have been confirmed to constitute a minority of ischemic stroke admissions, and data analyses have shown that 0.02% patients admitted to the hospital with ischemic stroke have PAVMs (<xref rid="ref50" ref-type="bibr">50</xref>).</p><p>Based on a series of epidemiologic studies, approximately 4.3&#8211;45.3% of PAVM population experience proven ischemic stroke (<xref rid="ref18" ref-type="bibr">18</xref>, <xref rid="ref19" ref-type="bibr">19</xref>, <xref rid="ref29" ref-type="bibr">29&#8211;35</xref>) (<xref rid="tab1" ref-type="table">Table 1</xref>). Interestingly, PAVM-related ischemic stroke presents in a younger demographic. In a large retrospective study enrolling 4,271,910 patients with acute ischemic stroke, patients with both stroke and PAVMs were younger than those patients without PAVMs (57.5&#8201;years vs. 72.5&#8201;years), suggesting that PAVM-related stroke may be independent of other strokes in terms of clinical characteristics (<xref rid="ref50" ref-type="bibr">50</xref>). Moreover, stroke patients with PAVMs had lower age-adjusted crude inpatient morbidity (39.6% vs. 46.9%) and in-hospital case fatality rates (1.8% vs. 5.1%) (<xref rid="ref50" ref-type="bibr">50</xref>). Also, in another cohort study enrolling 497 patients with CT-proven PAVMs due to HHT, 61 patients (12.3%) had acute, non-iatrogenic ischemic clinic stroke at a younger age (median age of 52&#8201;years) (<xref rid="ref30" ref-type="bibr">30</xref>). In addition, the stroke distribution type is different among these patients. The majority of patients (70.5%) had partial anterior circulation syndromes, while fewer had partial posterior circulation syndromes (27.9%) or lacunar circulation syndrome (1.6%) (<xref rid="ref30" ref-type="bibr">30</xref>). However, there was no difference in ages between the stroke distribution types.</p><p>Patients with multiple PAVMs always have a higher incidence of cerebral infarct compared to patients with single PAVMs (<xref rid="ref18" ref-type="bibr">18</xref>). In one retrospective cross-sectional study, Moussouttas et al. (<xref rid="ref18" ref-type="bibr">18</xref>) found that the incidence of cerebral infarction increased from 32% in patients with a single PAVM to 60% in those with multiple PAVMs among a cohort sample including 26 single PAVMs and 49 multiple PAVMs. These significant differences in infarction prevalence between the two groups suggested an increased predisposition to neurologic complications in patients with greater numbers of malformations.</p><p>Silent cerebral infarction (SBI) is characterized by the incidental finding of cerebral infarction on imaging without any clinically apparent neurological deficit (<xref rid="ref51" ref-type="bibr">51</xref>). However, SBI is not a completely silent and benign event, and mounting evidence suggests that multiple SBIs independently increase the risk of recurrent ischemic stroke (<xref rid="ref52" ref-type="bibr">52</xref>). These lesions are frequently associated with neurological deficits and early mortality (<xref rid="ref51" ref-type="bibr">51</xref>). Among PAVM patients, the burden of SBI is more than that of clinical stroke and should not be ignored. In a recent small study including 29 PAVM patients with no previous history of clinical stroke, 16 patients (55.2%) had between one and five SBIs assessed by magnetic resonance38. Moreover, the most frequently affected sites were the cerebellum (40%) and thalamus (14.3%) (<xref rid="ref36" ref-type="bibr">36</xref>). Further studies were performed by Brinjikji et al. (<xref rid="ref53" ref-type="bibr">53</xref>), who found that the prevalence of SBIs increased with age, affecting 0, 10, 28.6, and 27.6% of patients with PAVMs who were &lt;30, 30&#8211;39, 60&#8211;69, and &#8805;70&#8201;years old, respectively, while they affected 0, 0, 10.5, and 10.5%, respectively, in patients without PAVMs. Thus, the patients with PAVMs experience a higher prevalence of SBIs than the general population, particular in patients over the age of 60&#8201;years old. Multivariate analysis indicated that only PAVMs and increasing age are independently associated with SBI (<xref rid="ref53" ref-type="bibr">53</xref>). Evidences showed paradoxical embolism is involved the pathogenesis of SBI (<xref rid="ref51" ref-type="bibr">51</xref>, <xref rid="ref54" ref-type="bibr">54</xref>). In the ICONS study, the prevalence of right-to-left shunt among those individuals with SBI located outside the perforating artery territory was similar to that of cryptogenic embolic stroke (51% vs. 62%) (<xref rid="ref54" ref-type="bibr">54</xref>).</p><p>Based on prior studies, PAVMs appear to be a novel risk for ischemic stroke. Therefore, recognizing the higher risk of stroke in order to facilitate appropriate management strategies among PAVM patients is particularly important. In the PAVM population, the risk of ischemic stroke may be attributable not to conventional vascular risk factors, but to the severity of PAVMs. Previous studies showed that there was no association between the conventional neurovascular risk factor and ischemic stroke in patients with PAVMs (<xref rid="ref2" ref-type="bibr">2</xref>). Attention then focused on the diameter of the feeding artery and the degree of right-to-left shunt, which is considered to be associate with an increased risk of neurological complications in patients with PAVMs. Etievant et al. (<xref rid="ref19" ref-type="bibr">19</xref>) analyzed the data from a total of 170 patients with PAVMs and found an association between the mean diameter of the largest feeding artery of the PAVMs and ischemic stroke frequency, suggesting that a larger feeding artery is more strongly related to the risk of ischemic strokes. However, there have been some conflicting reports, and there is evidence that stroke risks cannot be predicted by respiratory symptoms or PAVM severity in PAVM patients. In the study by Shovlin et al. (<xref rid="ref29" ref-type="bibr">29</xref>), they did not find an association between the primary determinants of stroke risks and PAVM severity. In addition, Moussouttas et al. (<xref rid="ref18" ref-type="bibr">18</xref>) showed that the prevalence of cerebral infarction did not appear to be related to larger feeding artery diameters when the diameters exceeded 3&#8201;mm in patients with single PAVMs, and no increased risk for cerebral infarction was seen when the feeding artery was less than 3&#8201;mm. Based on these findings, other factors might be involved in the pathogenesis of severe neurological manifestations in patients with PAVMs. Prior studies have reported that patients with PAVMs combined with iron deficiency may have an increased risk of ischemic stroke. In one retrospective cohort study of 497 patients with CT-proven PAVMs, ischemic strokes were more common in those patients with low serum iron. Among PAVM patients, the risk of stroke was approximately double for a serum iron concentration of 6&#8201;&#956;mol/L compared to a serum iron level in the mid-normal range (7&#8211;27&#8201;&#956;mol/L), suggesting that stroke risk may be inversely associated with low serum iron rather than with venous thromboemboli, conventional neurovascular risk factors, or the severity of the right-to-left shunt (<xref rid="ref2" ref-type="bibr">2</xref>). The pathogenesis may be associated with enhanced platelet aggregation responses induced by iron deficiency. Interestingly, ischemic stroke appeared more common in patients who had experienced at least one myocardial infarction. Even after adjusting for all other measured variables, this association persisted, suggesting the involvement of paradoxical embolic aetiology (<xref rid="ref2" ref-type="bibr">2</xref>).</p><p>The use of antiplatelet agents for the prevention of ischemic stroke caused by PAVMs has been recommended in guidelines (<xref rid="ref55" ref-type="bibr">55</xref>). Although there might be a higher risk of nosebleeds, patients with HHT/PAVMs tolerate antiplatelet or anticoagulant therapy better than expected (<xref rid="ref56" ref-type="bibr">56</xref>). In addition, the benefit of therapeutic PAVM occlusion in preventing the recurrence of ischemic events in PAVM patients with stroke has been established (<xref rid="ref16" ref-type="bibr">16</xref>).</p><p>The presence of patent foramen ovale (PFO) also provides a channel to permit the right to left shunting of embolic material to the brain, and PAVMs are often misdiagnosed as PFO. In clinical practice, PAVMs and PFO may be coexist in some patients (<xref rid="ref49" ref-type="bibr">49</xref>, <xref rid="ref57" ref-type="bibr">57</xref>, <xref rid="ref58" ref-type="bibr">58</xref>). The existence of an isolated PAVM in patients with cryptogenic stroke should not be overlooked, even if a PFO is present. PAVMs can arise as residual defects after PFO closure, and it has been reported that some patients have recurrent cerebrovascular events after the closure of a PFO (<xref rid="ref49" ref-type="bibr">49</xref>, <xref rid="ref57" ref-type="bibr">57</xref>).</p><p>Considering the prevalence of PAVMs in the population, it can be estimated that PAVMs should be responsible for a significant portion of stroke patients. It has been reported that approximately 1 in 1,000 acute ischemic stroke hospitalizations can be attributed to a PAVM, while only 1 in 5,000 was captured (<xref rid="ref59" ref-type="bibr">59</xref>). Therefore, unexplained cryptogenic stroke should raise the suspicion of the presence of PAVMs, and thus a better understanding of risk factors for PAVM patients who may develop stroke is important.</p></sec><sec id="sec7"><label>4.1.2</label><title>Cerebral abscess</title><p>Cerebral abscesses always leads to unfavorable prognosis, including death, and among those who survive 80% of patients are unable to return to their former occupation because of persistent neurological deficits (<xref rid="ref29" ref-type="bibr">29</xref>). Accumulating evidence suggests that patients with PAVMs have a considerable risk of suffering from cerebral abscesses. A series of epidemiological studies showed that about 3.5&#8211;19% of PAVM patients are complicated with cerebral abscess, often located at the basal ganglia (<xref rid="ref18" ref-type="bibr">18</xref>, <xref rid="ref19" ref-type="bibr">19</xref>, <xref rid="ref23" ref-type="bibr">23</xref>, <xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref31" ref-type="bibr">31</xref>, <xref rid="ref32" ref-type="bibr">32</xref>, <xref rid="ref37" ref-type="bibr">37</xref>, <xref rid="ref38" ref-type="bibr">38</xref>, <xref rid="ref60" ref-type="bibr">60</xref>). In general, most PAVM patients experience a cerebral abscess within their first 50&#8201;years of life (<xref rid="ref38" ref-type="bibr">38</xref>). However, the majority of PAVM-induced cerebral abscesses may be the initial clinical manifestation, and these commonly occur in asymptomatic subjects who have not yet received a diagnosis of PAVMs (<xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref38" ref-type="bibr">38</xref>). There is always a delay between the abscess event and later PAVM diagnosis, so patients with unexplained cerebral abscess should be evaluated for PAVMs (<xref rid="ref37" ref-type="bibr">37</xref>).</p><p>PAVM patients with cerebral abscesses are more likely to have multiple PAVMs. A study showed that the prevalence of brain abscesses in patients with multiple PAVMs was twice that compared to patients with a single PAVM (<xref rid="ref18" ref-type="bibr">18</xref>). However, considering the small sample of only 75 individuals in that study, more promising results might be obtained when the sample size is enlarged. In PAVM patients, the cerebral abscesses may be isolated or multiple (<xref rid="ref15" ref-type="bibr">15</xref>). Of these, most cases are multiple or recurrent, which could lead to substantial morbidity and healthcare burdens in PAVM patients (<xref rid="ref31" ref-type="bibr">31</xref>). In one retrospective cohort study including 445 patients diagnosed with PAVMs, 37 patients (8.3%) experienced a cerebral abscess and all required neurosurgery, longer antibiotic therapy, and prolonged inpatient hospital stays. Moreover, more than half of the cases (19 of 37 cases, 51.4%) suffered residual life-changing neurological deficits, most commonly including memory loss or other cognition impairment, hemiparesis, and visual defects (<xref rid="ref38" ref-type="bibr">38</xref>).</p><p>The pulmonary capillary bed normally provides a first-pass filtration system that can remove small thrombi and bacteria before they enter the circulation. Because of the lack of proper filtration by the pulmonary capillary bed in PAVMs, the capacity to eliminate bacteria or infected material is damaged. Thus the bacteria or infected material are able to pass through the PAVM and into the cerebral circulation, which can result in an abscess (<xref rid="ref7" ref-type="bibr">7</xref>, <xref rid="ref39" ref-type="bibr">39</xref>). Recently, the association between PAVM-induced cerebral abscess and microbial species has been a focus of research. Boother et al. (<xref rid="ref38" ref-type="bibr">38</xref>) found that bacterial species cultured from PAVM patients with cerebral abscesses were microaerophilic and anaerobic bacteria predominantly of odontogenic origin.</p><p>Recently, a linear association between low oxygen saturation (indicating greater right-to-left shunt) and the risk of cerebral abscesses has been established among PAVM patients (<xref rid="ref38" ref-type="bibr">38</xref>). For each 1% rise in oxygen saturation, the risk of cerebral abscess is reduced by 10.47% (<xref rid="ref38" ref-type="bibr">38</xref>). It is expected that the risks of neurotic compilations (including stroke and cerebral abscess) can be evaluated based on the severity of right-to-left shunting in PAVM patients. Recently, Velthuis et al. (<xref rid="ref39" ref-type="bibr">39</xref>) showed that the presence of cerebral manifestations (including ischemic stroke, TIA, or cerebral abscess) differed significantly according to pulmonary shunt grade (grade 0, 1, 2, and 3 pulmonary shunt corresponding to 1.4, 0.4, 6.5, and 20.9%, respectively) in patients screened for HHT, suggesting a striking association between pulmonary right-to-left shunt grade and the prevalence of cerebral complications. Moreover, pulmonary shunt grade 2 and 3 are both independent predictors for the prevalence of a cerebral ischemic event or abscess. However, some conflicting results have been also reported. In one study by Etievant et al. (<xref rid="ref19" ref-type="bibr">19</xref>), an increased risk of cerebral abscess was found in those patients with multiple, diffuse, or disseminated PAVMs, but no increased risk with increased severity of the right-to-left shunt, indicating an association between the number of PAVMs and the prevalence of brain abscesses. Another contradicting study was that of Velthuis et al. (<xref rid="ref39" ref-type="bibr">39</xref>), where the risk of cerebral abscess failed to be predicted by the size, severity, or symptoms of PAVMs in patients. They argued that there was no significant relationship between cerebral abscess and PAVM severity markers (<xref rid="ref29" ref-type="bibr">29</xref>). Moreover, another study found no relationship between cerebral abscess risk and other PAVMs-related neurological complications (such as ischemic stroke and migraine headaches), variables associated with ischemic stroke risk, or the diameter of the largest PAVM-feeding artery (<xref rid="ref38" ref-type="bibr">38</xref>). Based on these conflicting results, whether shunt size and PVAM severity should be taken into consideration when evaluating the potential risk of neurological complications requires further study.</p><p>In addition, males with PAVMs present with higher cerebral abscess rates (<xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref38" ref-type="bibr">38</xref>). In one retrospective cohort study, the majority (60.7%) of PAVM patients with brain abscesses were male (<xref rid="ref29" ref-type="bibr">29</xref>). In another retrospective study analyzing the data from a total of 445 patients with confirmed PAVMs, multivariate logistic regression showed that the prevalence of cerebral abscess was associated with male sex and was estimated to be 2.63-fold higher than in females and was also associated with low oxygen saturation and venous thromboemboli. Unexpectedly, the risk of cerebral abscess was greater in patients with a higher transferrin iron saturation index and in those receiving intravenous iron supplementation (<xref rid="ref38" ref-type="bibr">38</xref>).</p><p>It is important to screen for patients with PAVMs who are at risk for cerebral abscess even though the majority of individuals are asymptomatic. For patients with confirmed cerebral abscesses, prompt and full antibiotic treatment is needed. In addition, antibiotic prophylaxis for procedures with a risk of bacteremia is also be recommended due to the potential risk of cerebral abscess (<xref rid="ref6" ref-type="bibr">6</xref>).</p></sec><sec id="sec8"><label>4.1.3</label><title>TIA</title><p>A TIA is an important predictor of stroke, and TIAs and stroke share similar pathophysiologic mechanisms to some extent. Of note, the 90-day risk of stroke may be up to 17% after a TIA (<xref rid="ref55" ref-type="bibr">55</xref>). Moreover, the greatest risk is in the first week. In most instances TIA and stroke have identical preventive strategies, but the prognosis may vary depending on severity and cause (<xref rid="ref55" ref-type="bibr">55</xref>).</p><p>PAVM patients can experience TIAs. In one retrospective multicenter study enrolling 126 patients with PAVMs, 35% patients had ischemic central nervous system events and TIA attack was reported in 6.3% of patients (<xref rid="ref23" ref-type="bibr">23</xref>). Also, in a total of 208 PAVM patients, a significantly higher prevalence of TIA was found compared to those without PAVM (8.7% vs. 1.2%) (<xref rid="ref32" ref-type="bibr">32</xref>). Percutaneous embolization can effectively low the risk of TIA in PAVM patients. In a case study, a 65-year-old woman with a history of multiple TIAs was diagnosed with PAVMs and received catheter closure. Over 2&#8201;years of follow-up, the patient did not have any further episodes of TIA or stroke and her neurological symptoms were completely resolved (<xref rid="ref61" ref-type="bibr">61</xref>). Although some PAVM patients successfully received embolotherapy, they might experience TIA during follow-up because of recanalization of PAVMs (<xref rid="ref40" ref-type="bibr">40</xref>). Patients should remain under regular review after embolotherapy.</p></sec><sec id="sec9"><label>4.1.4</label><title>Cerebral hemorrhage</title><p>Among PAVM patients, the risk of cerebral hemorrhage is low compared with other cerebral events (stroke, cerebral abscess, and TIA). Prior studies have reported that cerebral hemorrhage is only present in 2.4% of patients and accounts for only 5.7% of central nervous system events in PAVM patients (<xref rid="ref23" ref-type="bibr">23</xref>). Of note, these malformations appeared more often in PAVM patients combined with HHT.</p></sec><sec id="sec10"><label>4.1.5</label><title>Migraine</title><p>As a common neurovascular brain disorder, migraine seriously affects individuals&#8217; quality of life and results in significant economic burden. However, the symptoms and clinical features of migraine are complex and variable, and the pathogenesis remains poorly understood. Therefore, many different treatment strategies have been implemented. The relationship between cardiopulmonary pathology and migraine has been illustrated by a series of studies, and an association between migraine and right-to-left shunt has been established (<xref rid="ref62" ref-type="bibr">62</xref>). Abnormal shunting can lead to the passing of paradoxical microemboli through the open physiological channels in PAMVs and lead to production-inactivation imbalances of some neurotransmitters that are released into circulation instead of being trapped in the pulmonary capillaries (<xref rid="ref26" ref-type="bibr">26</xref>, <xref rid="ref63" ref-type="bibr">63</xref>). The microemboli and/or chemical substances in venous blood may initiate cortically spreading depression and can trigger an attack of migraine when they arrive at the brain in sufficient concentrations through the abnormal shunt, which establish a plausible link between PAVMs and migraine (<xref rid="ref62" ref-type="bibr">62</xref>, <xref rid="ref64" ref-type="bibr">64</xref>, <xref rid="ref65" ref-type="bibr">65</xref>). For example, 5-hydroxytryptamine (5-HT), which is normally eliminated on passage through the lungs, has been reported to be involved the pathogenesis of migraine (<xref rid="ref66" ref-type="bibr">66</xref>). Drugs that influence 5-HT receptors have been reported to be used in treating migraine (<xref rid="ref66" ref-type="bibr">66</xref>).</p><p>A higher prevalence of migraine headache symptoms in PAVM patients has been reported in prior cohort studies, with an incidence of 4&#8211;38% (<xref rid="ref6" ref-type="bibr">6</xref>). In one study by Maher et al. (<xref rid="ref31" ref-type="bibr">31</xref>), among 71 patients with PAVMs, 18 (25.4%) had a known history of migraine headaches. Given that approximately 15% of the general population globally are affected by migraine (<xref rid="ref67" ref-type="bibr">67</xref>), this finding might represent an increase over the normal incidence of migraine headache. Kakehi et al. (<xref rid="ref65" ref-type="bibr">65</xref>) reported a 40-year-old woman with a history of migraine for 30&#8201;years who was diagnosed with PAVMs. A case of PAVMs in a woman aged 41&#8201;years who suffered from migraine with optic aura once or twice every month for over 20&#8201;years was also presented in the study by Kakeshita et al. (<xref rid="ref68" ref-type="bibr">68</xref>). After transcatheter embolization, the two patients had no episodes of migraine. Although the migraine was resolved in the two patients after successful closure of the PAVMs, the effectiveness of PAVM closure in treating migraine has not been confirmed. Anti-platelet therapy also achieved significant therapeutic efficacy in some cases. For example, Onorato et al. (<xref rid="ref69" ref-type="bibr">69</xref>) described a 38-year-old woman suffering from episodes of migraine with aura caused by an isolated PAVM, and after thienopyridine therapy, not embolization, the migraine symptoms were almost completely resolved. Therefore, further population-based studies are needed to develop appropriate strategies for treating migraine in patients with PAVMs.</p><p>Numerous clinic-based studies have shown that patients with migraine among all population groups are at higher risk for stroke (<xref rid="ref67" ref-type="bibr">67</xref>). In a large Danish study enrolling 51,032 patients with migraine over 19&#8201;years of follow-up, the risk of ischemic and hemorrhagic stroke was significantly increased compared with the general population, suggesting that migraine is an important risk factor for stroke (<xref rid="ref70" ref-type="bibr">70</xref>). Recently, Zhang et al. (<xref rid="ref63" ref-type="bibr">63</xref>) found that migraine patients with grade 2 or 3 right-to-left shunting may be more likely to develop stroke. However, that study focused on PFO-related right-to-left shunt, not PAVM-related right-to-left shunt. Considering the difference between the two diseases, whether those PAVM patients with migraine who have higher grades of right-to-left shunting are at greater risk of suffering a stroke requires more study.</p></sec><sec id="sec11"><label>4.1.6</label><title>Seizure</title><p>Seizure is frequently seen in patients with PAVMs. Moussouttas et al. (<xref rid="ref18" ref-type="bibr">18</xref>) analyzed the data from 75 consecutive patients admitted to Yale-New Haven Hospital between 1988 and 1992 for treatment for PAVMs, and they found that 14.7% of patients developed seizure. The incidence of seizures in patients with multiple PAVMs was at least twice that in patients with a single PAVM. Moreover, seizures in patients with multiple PAVMs were associated with the occurrence of cortical infarctions and brain abscesses.</p></sec><sec id="sec12"><label>4.1.7</label><title>Dizziness</title><p>Simple PAVM-related dizziness is rare and is only mentioned in sporadic case reports. In one study by Cao (<xref rid="ref71" ref-type="bibr">71</xref>), a 73-year-old woman experienced recurrent dizziness for more than 10&#8201;months without hypoxemia, hemiplegia, or altered consciousness, and a PAVM was found in her left upper lobe. After percutaneous PAVM embolization, the patient&#8217;s dizziness was relieved without recurrence. However, the patient had a history of hypertension and atherosclerosis and received anti-platelet and blood pressure-lowering therapy, so medical treatment cannot be entirely excluded in eliminating the dizziness.</p><p>Brain manifestations are frequent and dangerous in PAVM patients. Considering that neurological PAVM-associated risks are common, PAVM patients should be screened and aggressively managed, even for asymptomatic PAVMs. Surprisingly, there is no significant difference in the risk of central nervous system complications in patients with single and with multiple PAVMs, suggesting that similar attention should be paid to patients with single and multiple PAVMs (<xref rid="ref23" ref-type="bibr">23</xref>). In PAVM patients, the risk of ischemic stroke and cerebral abscess can be reduced after embolization. Unfortunately, clinical practice guidelines addressing the acute management and secondary prevention of neurological syndromes (ischemic stroke, cerebral abscess, and TIA) in patients with PAVMs remain rare (<xref rid="ref59" ref-type="bibr">59</xref>). Whether these PAVMs should be treated once they are discovered requires further study.</p></sec></sec><sec id="sec13"><label>4.2</label><title>Cardiovascular disorders</title><sec id="sec14"><label>4.2.1</label><title>Cardiac failure</title><p>In general, PAVMs do not influence cardiac hemodynamics. However, patients may be symptomatic when the right-to-left shunt is greater than 20% of the systemic cardiac output (<xref rid="ref72" ref-type="bibr">72</xref>). Increased cardiac output can result in heart failure (<xref rid="ref73" ref-type="bibr">73</xref>, <xref rid="ref74" ref-type="bibr">74</xref>). Liao et al. (<xref rid="ref73" ref-type="bibr">73</xref>) described an unusual case presenting with refractory heart failure with a moderately dilated left ventricle and significantly decreased left ventricle ejection fraction caused by PAVMs.</p><p>Pulmonary load is a central determinant of right ventricular (RV) systolic function. The RV dysfunction can result in the dilatation of right ventricle and subsequent heart failure (<xref rid="ref75" ref-type="bibr">75</xref>). The occurrence of pulmonary arterial hypertension (PAH) is associated with RV dysfunction. In theory, the development of PAVMs may decrease the pulmonary arterial pressure and unload the right ventricle, and PAVM embolism may increase the pulmonary arterial pressure and RV afterload, thus predisposing the patients to right heart failure in the presence of PAH (<xref rid="ref76" ref-type="bibr">76</xref>). However, heterogeneous results have been published. Shovlin et al. (<xref rid="ref77" ref-type="bibr">77</xref>) studied 143 cases and showed that there was no significant increase in pulmonary artery pressure or right heart failure as a result of PAVM embolisation. It should be noted, however, that patients with severe PAH were excluded from the study. Thus, more studies are needed to predict the outcomes of patients with cardiac involvement.</p></sec><sec id="sec15"><label>4.2.2</label><title>Arrhythmia</title><p>Some patients with PAVMs present with arrhythmia. As documented by the study by Santhirapala et al. (<xref rid="ref78" ref-type="bibr">78</xref>), 29% (74 of 257) of PAVM patients had postural orthostatic tachycardia, and this was more pronounced in patients with orthodeoxia than in patients without orthodeoxia. The occurrence of orthostatic tachycardia may be part of acute compensatory mechanisms that maintain tissue oxygen delivery when the arterial oxygen content is falling (<xref rid="ref78" ref-type="bibr">78</xref>).</p></sec><sec id="sec16"><label>4.2.3</label><title>Myocardial infarction</title><p>PAVMs can manifest as cardiac ischemic events due to paradoxical embolism. In a single-center study enrolling 98 patients with PAVMs, 6 patients experienced typical angina pectoris-like chest pain or had a myocardial infarction before PAVM embolotherapy (<xref rid="ref79" ref-type="bibr">79</xref>). The occurrence of cardiac ischemia may be caused by a paradoxical embolus passing through the PAVMs to a coronary artery (<xref rid="ref79" ref-type="bibr">79</xref>).</p></sec></sec><sec id="sec17"><label>4.3</label><title>Pulmonary disorders</title><sec id="sec18"><label>4.3.1</label><title>Hypoxemia and dyspnea</title><p>In PAVMs, blood flows directly from the pulmonary artery to the pulmonary vein because of the right-to-left shunt, thus bypassing the capillary-alveolar barrier with no effective gas exchange. Therefore, PAVMs impair normal gas exchange and can lead to hypoxemia and dyspnea as well as enhanced ventilatory demands (<xref rid="ref2" ref-type="bibr">2</xref>). The impairment of gas exchange mainly depends on the size of the PAVMs (<xref rid="ref27" ref-type="bibr">27</xref>). A smaller physiologic burden in intrapulmonary right&#8211;left shunt does not affect blood oxygenation (<xref rid="ref80" ref-type="bibr">80</xref>), Therefore, PAVM patients rarely present with dyspnea or respiratory syndromes and are usually asymptomatically hypoxemic (<xref rid="ref81" ref-type="bibr">81</xref>). The degree of right-to-left shunt determines the severity of hypoxemia, with severe hypoxemia occurring when the shunt is more than 20% of the cardiac output (<xref rid="ref6" ref-type="bibr">6</xref>). Thus, serious hypoxemia may appear in patients with more diffuse and severe types of PAVMs (<xref rid="ref6" ref-type="bibr">6</xref>). In addition, orthodeoxia is often noted due to PAVMs that are commonly located in the lower lobes, middle lobes, and the lingula (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref21" ref-type="bibr">21</xref>, <xref rid="ref82" ref-type="bibr">82</xref>). Santhirapala et al. (<xref rid="ref78" ref-type="bibr">78</xref>) enrolled 258 patients with PAVMs and assessed their postural changes using validated pulse oximetry methods. They found that 29% of the patients had orthodeoxia with an oxygen saturation drop of at least 2% on standing. Acute drops in oxygen saturation will induce a decrease in the arterial oxygen content per unit blood volume. Fortunately, PAVM-associated platypnea is rarely experienced, suggesting that acute drops in arterial oxygen content can be successfully compensated for in the PAVM population (<xref rid="ref78" ref-type="bibr">78</xref>). Moreover, pulmonary vascular resistance at rest is low in PAVM patients, and hypoxemic PAVM patients are not considered to be at risk of hypoxic pulmonary hypertension (<xref rid="ref83" ref-type="bibr">83</xref>).</p><p>Although long-term oxygen therapy can be used to improve hypoxemia, whether it is beneficial in PAVMs patients remains controversial. Moreover, there is no evidence that supplemental oxygen application can decrease the risk of PAVMs-related complications, although oxygen therapy may of course be indicated when PAVM patients have comorbidities such as neurological and cardiovascular disorders (<xref rid="ref84" ref-type="bibr">84</xref>). After embolization, the patients will have a secondary erythrocytic response and restored oxygen saturation (<xref rid="ref81" ref-type="bibr">81</xref>, <xref rid="ref83" ref-type="bibr">83</xref>). Moreover, this improvement will persist for a long period. However, the majority of patients have no change in exercise at their post-embolization follow-up (<xref rid="ref83" ref-type="bibr">83</xref>). Hypoxemic patients still maintain normal oxygen delivery/consumption during peak exercise in the PAVMs patient population, utilizing both secondary erythrocytosis and the maintenance of the oxygen pulse (<xref rid="ref81" ref-type="bibr">81</xref>).</p></sec><sec id="sec19"><label>4.3.2</label><title>Hemoptysis and hemothorax</title><p>PAVMs occasionally manifest as a clinical emergency with hemoptysis or hemothorax caused by PAVM-associated hemorrhage (<xref rid="ref85" ref-type="bibr">85</xref>). Moreover, these patients are always complicated with HHT. In PAVMs, the angioarchitecture between the pulmonary artery and the pulmonary vein is fragile and may rupture and bleed as the PAVM size increases (<xref rid="ref6" ref-type="bibr">6</xref>). The incidence of PAVM rupture ranges from 2 to 8% (<xref rid="ref86" ref-type="bibr">86</xref>). The rupture of PAVMs can induce hemoptysis or hemothorax because PAVMs are usually subpleural (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref82" ref-type="bibr">82</xref>). Elmali et al. (<xref rid="ref87" ref-type="bibr">87</xref>) described a 51-year-old woman with sudden-onset chest pain who was diagnosed with PAVMs by thoracic CT angiography, and the patient underwent thoracentesis and hemorrhagic fluid was found. Although significant PAVM-associated pulmonary hemorrhages are a life-threatening complication, their incidence is rare. One prior multicenter study showed that 12% (15 of 126) of patients had hemoptysis, but only one patient was severe, and only 4 patients (3%) presented with hemothorax (<xref rid="ref23" ref-type="bibr">23</xref>). Ference et al. (<xref rid="ref88" ref-type="bibr">88</xref>) showed that only 11 patients (8%) developed a history of either massive hemoptysis or hemothorax in another retrospective study of 143 patients with PAVMs and HHT, and only one patient died. It is agreed that pulmonary hemorrhage caused by the rupture of the PAVMs should be treated aggressively with transcatheter embolotherapy or surgical intervention (<xref rid="ref88" ref-type="bibr">88</xref>). However, which PAVMs are most likely to rupture remains difficult to predict.</p><p>The presence of PAH predisposes for the enlargement of PAVMs and subsequent rupture, but rupture generally only occurs in patients who have thin-walled PAVMs or in pregnant patients (<xref rid="ref76" ref-type="bibr">76</xref>). Recent case reports highlighted the risk. A PAVM with a 5-mm diameter feeding artery in the right lower lobe was reported in a 29-year-old patient combined with HHT and PAH. Although hemodynamics were improved after dual endothelin receptor antagonist and inhaled iloprost, the patient died suddenly of a rupture of the PAVM into the pleural cavity (<xref rid="ref89" ref-type="bibr">89</xref>). A good outcome was reported in a 28-year-old male presenting with an 8-year history of recurrent hemoptysis and a year of chest pain, which was confirmed as PAH and diffuse PAVMs. After treatment with sildenafil for 1&#8201;year, the symptoms of hemoptysis disappeared in this patient (<xref rid="ref90" ref-type="bibr">90</xref>).</p><p>Although PAVM-associated hemorrhage is rare, it is the most common contributor to the 1% rate of maternal death in pregnancy (<xref rid="ref2" ref-type="bibr">2</xref>, <xref rid="ref91" ref-type="bibr">91</xref>). The increased risk for rupture and hemorrhage in the pregnant population with PAVMs may be associated with increased cardiac output and decreased vascular wall stability (<xref rid="ref1" ref-type="bibr">1</xref>). Pregnancy has been regarded as a hazardous period for women with PAVMs (<xref rid="ref79" ref-type="bibr">79</xref>). Prior recognition of HHT or PAVM diagnosis and provision of additional care can contribute to improving survival outcome in women experiencing a life-threatening event (<xref rid="ref91" ref-type="bibr">91</xref>).</p></sec><sec id="sec20"><label>4.3.3</label><title>Cough</title><p>PAVMs can be responsible for the occurrence of chronic cough. However, this is only published in the case report-biased literature and lacks systematic reporting. In 2015, Jutant et al. (<xref rid="ref92" ref-type="bibr">92</xref>) reported a 51-year-old female who suffered from severe chronic cough caused by PAVMs. After surgical intervention, the cough completely disappeared. Unfortunately, the exact mechanism through which a PAVM can cause coughing remains elusive. It is speculated that the irritation of the pleura due to the sub-pleural location of the arteriovenous malformations may be involved (<xref rid="ref92" ref-type="bibr">92</xref>).</p></sec><sec id="sec21"><label>4.3.4</label><title>Respiratory failure</title><p>PAVM patients rarely present with acute respiratory failure, and such presentations are limited to case reports. Recently, Nusca et al. (<xref rid="ref93" ref-type="bibr">93</xref>) reported a 54-year-old male who was admitted for acute respiratory failure with reduced oxygen saturation (90%) and mild distal-limb cyanosis attributed to the presence of a voluminous PAVM. After successfully percutaneous embolization, the arterial saturation increased to 99%.</p></sec></sec><sec id="sec22"><label>4.4</label><title>PAVM-related splanchnic vessels embolization</title><p>PAVMs are accompanied by paradoxical embolism in many organs due to the right-to-left shunt, thereby likely resulting in splanchnic vessel embolization. Prior studies reported that PAVMs can induce the occurrence of renal infarction, superior mesenteric arterial infarction, splenic infarction, and abscesses (<xref rid="ref94" ref-type="bibr">94</xref>, <xref rid="ref95" ref-type="bibr">95</xref>). However, it is very rare for PAVMs to be complicated by splanchic vessel embolization, and most are sporadic cases (<xref rid="ref96" ref-type="bibr">96</xref>).</p></sec></sec><sec id="sec23"><label>5</label><title>Treatment</title><p>Not all PAVMs require treatment. However, PAMV patients with neurologic complications, hypoxemia, or having a feeding artery &#8805;3&#8201;mm in diameter are recommended for active treatment. Percutaneous transcatheter embolotherapy and surgery are the main choices of treatment strategy, and percutaneous embolotherapy of the feeding artery of PAVMs is currently the first-line therapy due to its effectiveness, high level of safety, reduced invasiveness, and shorter hospital stay and because it is associated with reduced loss of lung tissue and low risk of complication. Embolization is amenable in the majority of cases and has effectively replaced surgery. Prior studies have shown the long-term efficacy of embolization with detachable balloons, metallic coils, and Amplatzer vascular plugs in the treatment of PAVMs (<xref rid="ref61" ref-type="bibr">61</xref>, <xref rid="ref97" ref-type="bibr">97</xref>). After successful closure of PAVMs, the patients usually have a good prognosis. However, although most cases are successfully treated, intervention strategies have the risk of recanalization, reperfusion, and downstream migration of the device with paradoxical embolism (<xref rid="ref92" ref-type="bibr">92</xref>, <xref rid="ref98" ref-type="bibr">98</xref>, <xref rid="ref99" ref-type="bibr">99</xref>). Recanalization accounts for more than 90% of persistent PAVMs after embolotherapy and is also the most common mechanism of PAVM reperfusion (<xref rid="ref85" ref-type="bibr">85</xref>, <xref rid="ref100" ref-type="bibr">100</xref>). Jutant et al. (<xref rid="ref92" ref-type="bibr">92</xref>) reported a 51-year-old female with PAVMs who underwent embolization; however, reperfusion was present in the previously embolized fistula and surgical excision of the malformation was ultimately undertaken. Recently, Takao et al. (<xref rid="ref98" ref-type="bibr">98</xref>) reported two cases that presented with cerebral infarction due to PAVM recanalization 13 and 30&#8201;years after the first coil embolization. Therefore, periodic follow-up is needed after catheter embolization. One retrospective study indicated that reperfusion may occur due to increased feeding artery diameter, an insufficient number of coils, the use of oversized coils, and proximal coil placement within the feeding artery more than 1&#8201;cm from the sac (<xref rid="ref85" ref-type="bibr">85</xref>).</p><p>Besides endovascular embolization of the feeding artery, transcatheter venous sac embolization (VSE) of PAVMs using interlocking detachable coils is an alternative method to the arterial route (<xref rid="ref101" ref-type="bibr">101</xref>, <xref rid="ref102" ref-type="bibr">102</xref>), and VSE may be beneficial in PAVMs with large out-flow vessels or short feeding arteries. Moreover, VSE may prevent the risk of systemic migration of embolic materials in PAVMs (<xref rid="ref101" ref-type="bibr">101</xref>). In a small retrospective study by Hayashi et al. (<xref rid="ref102" ref-type="bibr">102</xref>), 37 patients with PAVMs were enrolled to assess the efficacy of VSE (15 patients) and transcatheter feeding artery embolization (FAE, 22 patients) with coils for the treatment of PAVMs. Reperfusion occurred in 50% (11 of 22) of the patients in the FAE group and in no patients in the VSE group. Therefore, VSE is considered safe and to have long-term efficacy.</p><p>Despite surgical interventions requiring longer hospital stays and carrying a higher risk of complications, there are suggestions in the literature that minimally invasive anatomic lung resection by surgical treatment can be considered in select cases, especially for patients with diffuse lobar, segmental, solitary large PAVMs and for patients with complicated PAVMs or in cases of life-threatening bleeding after PAVM rupture (<xref rid="ref103" ref-type="bibr">103</xref>, <xref rid="ref104" ref-type="bibr">104</xref>). Nagano et al. (<xref rid="ref105" ref-type="bibr">105</xref>) performed a retrospective study among Japanese patients with PAVMs, including 211 cases who underwent surgery and 785 cases who underwent embolotherapy. Although a higher incidence of composite complications and prolonged postoperative hospital stay was noted in the patients who underwent surgery, surgery had a markedly lower rate of reintervention for PAVMs, suggesting that surgery had a higher curability compared to the patients who underwent embolotherapy. Next, Irie et al. (<xref rid="ref106" ref-type="bibr">106</xref>) documented the safety and efficacy of video-assisted thoracic surgery in treating idiopathic peripherally located simple-type PAVM. In this study, 23 patients were treated successfully with surgical resection and no serious complications were observed. Recently, Li et al. (<xref rid="ref107" ref-type="bibr">107</xref>) presented the case of a 44-year-old man with PAVM who had undergone transcatheter embolization three times but still relapsed. Moreover, he developed new symptoms of TIA after the third intervention. Fortunately, the patient received thoracoscopic surgery and no recurrence was observed. Despite transcatheter embolization being less invasive and being easier to repeat, repetitive interventional procedures increase the risk of potential complications, the duration of radiation exposure, and the dose of nephrotoxic contrast. In another study, a 55-year-old patient with a large PAVM complicated by hemothorax received transcatheter embolization. However, a subsequent emergency open thoracotomy was conducted due to active bleeding (<xref rid="ref108" ref-type="bibr">108</xref>). A larger diameter of the feeding artery may be responsible for the failure of embolization, and therefore transcatheter embolotherapy cannot guarantee success for all patients, especially in complicated cases. Surgery may thus be a reasonable treatment option for PAVM patients who are difficult to treat with embolotherapy or in refractory cases who have repeatedly experienced failed interventional procedures (<xref rid="ref109" ref-type="bibr">109</xref>).</p><p>Advances in catheter techniques have increased the proportion of patients who are eligible for embolotherapy. However, transcatheter embolization cannot completely replace surgical resection in all patients with PAVMs. Surgery as a choice of treatment strategy should therefore be considered in specific cases to achieve complete recovery. Altogether, current work in the field suggests that an individualized approach is necessary for the treatment of PAVMs.</p></sec><sec sec-type="conclusions" id="sec24"><label>6</label><title>Conclusion</title><p>PAVM patients are typically asymptomatic; however, they are at risk for a range of complications affecting the neurological, cardiovascular, respiratory, and hematological systems, which can sometimes lead to catastrophic and fatal outcomes. Therefore, screening for PAVMs in asymptomatic patients and implementing appropriate management strategies are crucial to prevent complications and improve outcomes, particularly since these patients may be in a treatable phase before the condition becomes life-threatening. Unfortunately, PAVMs are often not suspected until complications have already arisen. Consequently, identifying and treating PAVMs before major complications develop remains a significant challenge in clinical practice.</p><p>The management of PAVMs relies on a deeper understanding of the disease, which could facilitate the development of personalized therapeutic approaches. Our study reviews the etiology, classification, diagnosis, comorbidities, and treatment of PAVMs, with the goal of advancing current knowledge of the condition. An effective management strategy may reduce the incidence of complications in patients with PAVMs. Therefore, a coordinated multidisciplinary team, including respiratory specialists, thoracic surgeons, neurologists, cardiologists, hematologists, radiologists, epidemiologists, and geneticists, is often essential to prevent complications and optimize treatment for patients with PAVMs.</p></sec></body><back><sec sec-type="author-contributions" id="sec25"><title>Author contributions</title><p>WL: Writing &#8211; original draft, Writing &#8211; review &amp; editing. HD: Writing &#8211; original draft. YL: Writing &#8211; original draft. XM: Writing &#8211; original draft, Writing &#8211; review &amp; editing.</p></sec><sec sec-type="COI-statement" id="sec27"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="sec28"><title>Publisher&#8217;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saboo</surname><given-names>SS</given-names></name><name name-style="western"><surname>Chamarthy</surname><given-names>M</given-names></name><name name-style="western"><surname>Bhalla</surname><given-names>S</given-names></name><name name-style="western"><surname>Park</surname><given-names>H</given-names></name><name name-style="western"><surname>Sutphin</surname><given-names>P</given-names></name><name name-style="western"><surname>Kay</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Pulmonary arteriovenous malformations: diagnosis</article-title>. <source>Cardiovasc Diagn Ther</source>. (<year>2018</year>) <volume>8</volume>:<fpage>325</fpage>&#8211;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.21037/cdt.2018.06.01</pub-id>, PMID: <pub-id pub-id-type="pmid">30057879</pub-id><pub-id pub-id-type="pmcid">PMC6039795</pub-id></mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformations</article-title>. <source>Am J Respir Crit Care Med</source>. (<year>2014</year>) <volume>190</volume>:<fpage>1217</fpage>&#8211;<lpage>28</lpage>. doi: <pub-id pub-id-type="doi">10.1164/rccm.201407-1254CI</pub-id><pub-id pub-id-type="pmid">25420112</pub-id><pub-id pub-id-type="pmcid">PMC4315816</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakayama</surname><given-names>M</given-names></name><name name-style="western"><surname>Nawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Chonan</surname><given-names>T</given-names></name><name name-style="western"><surname>Endo</surname><given-names>K</given-names></name><name name-style="western"><surname>Morikawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Bando</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening</article-title>. <source>Intern Med</source>. (<year>2012</year>) <volume>51</volume>:<fpage>1677</fpage>&#8211;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.2169/internalmedicine.51.7305</pub-id><pub-id pub-id-type="pmid">22790125</pub-id></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cong</surname><given-names>CV</given-names></name><name name-style="western"><surname>Luong</surname><given-names>DV</given-names></name><name name-style="western"><surname>Anh</surname><given-names>TT</given-names></name><name name-style="western"><surname>Minh</surname><given-names>NN</given-names></name><name name-style="western"><surname>Ly</surname><given-names>TT</given-names></name><name name-style="western"><surname>Duc</surname><given-names>NM</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformation and inherent complications with solitary lung nodule biopsy-literature overview and case report</article-title>. <source>Radiol Case Rep</source>. (<year>2022</year>) <volume>17</volume>:<fpage>2353</fpage>&#8211;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.radcr.2022.04.003</pub-id>, PMID: <pub-id pub-id-type="pmid">35570867</pub-id><pub-id pub-id-type="pmcid">PMC9096463</pub-id></mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gossage</surname><given-names>JR</given-names></name><name name-style="western"><surname>Kanj</surname><given-names>G</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformations. A state of the art review</article-title>. <source>Am J Respir Crit Care Med</source>. (<year>1998</year>) <volume>158</volume>:<fpage>643</fpage>&#8211;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1164/ajrccm.158.2.9711041</pub-id><pub-id pub-id-type="pmid">9700146</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cartin-Ceba</surname><given-names>R</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>KL</given-names></name><name name-style="western"><surname>Krowka</surname><given-names>MJ</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformations</article-title>. <source>Chest</source>. (<year>2013</year>) <volume>144</volume>:<fpage>1033</fpage>&#8211;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.12-0924</pub-id><pub-id pub-id-type="pmid">24008954</pub-id></mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agarwal</surname><given-names>J</given-names></name><name name-style="western"><surname>LaBranche</surname><given-names>J</given-names></name><name name-style="western"><surname>Dhillon</surname><given-names>S</given-names></name><name name-style="western"><surname>Allison</surname><given-names>WT</given-names></name><name name-style="western"><surname>Jeerakathil</surname><given-names>T</given-names></name><name name-style="western"><surname>Vethanayagam</surname><given-names>D</given-names></name></person-group>. <article-title>Neurologic complications in hereditary hemorrhagic telangiectasia with pulmonary arteriovenous malformations: a systematic review</article-title>. <source>Can J Neurol Sci</source>. (<year>2023</year>) <volume>50</volume>:<fpage>561</fpage>&#8211;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.1017/cjn.2022.80</pub-id>, PMID: <pub-id pub-id-type="pmid">35686303</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>K</given-names></name><name name-style="western"><surname>Minematsu</surname><given-names>K</given-names></name><name name-style="western"><surname>Nakajima</surname><given-names>M</given-names></name></person-group>. <article-title>Isolated pulmonary arteriovenous fistula without Rendu&#8211;Osler&#8211;Weber disease as a cause of cryptogenic stroke</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. (<year>2004</year>) <volume>75</volume>:<fpage>311</fpage>&#8211;<lpage>3</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp.2003.018044</pub-id> PMID: <pub-id pub-id-type="pmid">14742615</pub-id><pub-id pub-id-type="pmcid">PMC1738901</pub-id></mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keinath</surname><given-names>K</given-names></name><name name-style="western"><surname>Vaughn</surname><given-names>M</given-names></name><name name-style="western"><surname>Cole</surname><given-names>N</given-names></name><name name-style="western"><surname>Gentry</surname><given-names>S</given-names></name></person-group>. <article-title>Exertional hypoxia in a healthy adult: a pulmonary arteriovenous malformation</article-title>. <source>BMJ Case Rep</source>. (<year>2019</year>) <volume>12</volume>:<fpage>e231981</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bcr-2019-231981</pub-id>, PMID: <pub-id pub-id-type="pmid">31645384</pub-id><pub-id pub-id-type="pmcid">PMC6827801</pub-id></mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanley</surname><given-names>M</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>O</given-names></name><name name-style="western"><surname>Chandra</surname><given-names>A</given-names></name><name name-style="western"><surname>Gage</surname><given-names>KL</given-names></name><name name-style="western"><surname>Gerhard-Herman</surname><given-names>MD</given-names></name><name name-style="western"><surname>Ginsburg</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>ACR appropriateness criteria clinically suspected pulmonary arteriovenous malformation</article-title>. <source>J Am Coll Radiol</source>. (<year>2016</year>) <volume>13</volume>:<fpage>796</fpage>&#8211;<lpage>800</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacr.2016.03.020</pub-id><pub-id pub-id-type="pmid">27209598</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LaBranche</surname><given-names>J</given-names></name><name name-style="western"><surname>Nahirniak</surname><given-names>S</given-names></name><name name-style="western"><surname>Vethanayagam</surname><given-names>D</given-names></name></person-group>. <article-title>Common bleeding disorders affecting individuals with hereditary hemorrhagic telangiectasia</article-title>. <source>Clin Invest Med</source>. (<year>2016</year>) <volume>39</volume>:<fpage>E1</fpage>&#8211;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.25011/cim.v39i1.26324</pub-id><pub-id pub-id-type="pmid">26833168</pub-id></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mora-Lujan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>A</given-names></name><name name-style="western"><surname>Alba</surname><given-names>E</given-names></name><name name-style="western"><surname>Sanchez-Corral</surname><given-names>MA</given-names></name><name name-style="western"><surname>Berrozpe</surname><given-names>A</given-names></name><name name-style="western"><surname>Cerda</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: risk factors and endoscopic findings</article-title>. <source>J Clin Med</source>. (<year>2019</year>) <volume>9</volume>:<fpage>82</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm9010082</pub-id>, PMID: <pub-id pub-id-type="pmid">31905627</pub-id><pub-id pub-id-type="pmcid">PMC7019907</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Folz</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Tennie</surname><given-names>J</given-names></name><name name-style="western"><surname>Lippert</surname><given-names>BM</given-names></name><name name-style="western"><surname>Werner</surname><given-names>JA</given-names></name></person-group>. <article-title>Natural history and control of epistaxis in a group of German patients with Rendu&#8211;Osler&#8211;Weber disease</article-title>. <source>Rhinology</source>. (<year>2005</year>) <volume>43</volume>:<fpage>40</fpage>&#8211;<lpage>6</lpage>. PMID: <pub-id pub-id-type="pmid">15844501</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Cillis</surname><given-names>E</given-names></name><name name-style="western"><surname>Burdi</surname><given-names>N</given-names></name><name name-style="western"><surname>Bortone</surname><given-names>AS</given-names></name><name name-style="western"><surname>D&#8217;Agostino</surname><given-names>D</given-names></name><name name-style="western"><surname>Fiore</surname><given-names>T</given-names></name><name name-style="western"><surname>Ettorre</surname><given-names>GC</given-names></name><etal/></person-group>. <article-title>Endovascular treatment of pulmonary and cerebral arteriovenous malformations in patients affected by hereditary haemorrhagic teleangiectasia</article-title>. <source>Curr Pharm Des</source>. (<year>2006</year>) <volume>12</volume>:<fpage>1243</fpage>&#8211;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.2174/138161206776361237</pub-id>, PMID: <pub-id pub-id-type="pmid">16611106</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labeyrie</surname><given-names>PE</given-names></name><name name-style="western"><surname>Courtheoux</surname><given-names>P</given-names></name><name name-style="western"><surname>Babin</surname><given-names>E</given-names></name><name name-style="western"><surname>Bergot</surname><given-names>E</given-names></name><name name-style="western"><surname>Touze</surname><given-names>E</given-names></name><name name-style="western"><surname>Pelage</surname><given-names>JP</given-names></name></person-group>. <article-title>Neurological involvement in hereditary hemorrhagic telangiectasia</article-title>. <source>J Neuroradiol</source>. (<year>2016</year>) <volume>43</volume>:<fpage>236</fpage>&#8211;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neurad.2016.02.005</pub-id>, PMID: <pub-id pub-id-type="pmid">27059009</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khurshid</surname><given-names>I</given-names></name><name name-style="western"><surname>Downie</surname><given-names>GH</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformation</article-title>. <source>Postgrad Med J</source>. (<year>2002</year>) <volume>78</volume>:<fpage>191</fpage>&#8211;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1136/pmj.78.918.191</pub-id>, PMID: <pub-id pub-id-type="pmid">11930021</pub-id><pub-id pub-id-type="pmcid">PMC1742331</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yusuf</surname><given-names>H</given-names></name><name name-style="western"><surname>Rasheed</surname><given-names>A</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Conrad</surname><given-names>MB</given-names></name><name name-style="western"><surname>Hetts</surname><given-names>SW</given-names></name></person-group>. <article-title>Identifying racial disparities in hereditary hemorrhagic telangiectasia</article-title>. <source>J Neurointerv Surg</source>. (<year>2023</year>) <volume>15</volume>:<fpage>1050</fpage>&#8211;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnis-2022-019162</pub-id>, PMID: <pub-id pub-id-type="pmid">36137744</pub-id></mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moussouttas</surname><given-names>M</given-names></name><name name-style="western"><surname>Fayad</surname><given-names>P</given-names></name><name name-style="western"><surname>Rosenblatt</surname><given-names>M</given-names></name><name name-style="western"><surname>Hashimoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Pollak</surname><given-names>J</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations</article-title>. <source>Neurology</source>. (<year>2000</year>) <volume>55</volume>:<fpage>959</fpage>&#8211;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1212/wnl.55.7.959</pub-id><pub-id pub-id-type="pmid">11061251</pub-id></mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Etievant</surname><given-names>J</given-names></name><name name-style="western"><surname>Si-Mohamed</surname><given-names>S</given-names></name><name name-style="western"><surname>Vinurel</surname><given-names>N</given-names></name><name name-style="western"><surname>Dupuis-Girod</surname><given-names>S</given-names></name><name name-style="western"><surname>Decullier</surname><given-names>E</given-names></name><name name-style="western"><surname>Gamondes</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: correlations between computed tomography findings and cerebral complications</article-title>. <source>Eur Radiol</source>. (<year>2018</year>) <volume>28</volume>:<fpage>1338</fpage>&#8211;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00330-017-5047-x</pub-id>, PMID: <pub-id pub-id-type="pmid">29018941</pub-id></mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>HN</given-names></name><name name-style="western"><surname>Hyun</surname><given-names>D</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformation and its vascular mimickers</article-title>. <source>Korean J Radiol</source>. (<year>2022</year>) <volume>23</volume>:<fpage>202</fpage>&#8211;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.3348/kjr.2021.0417</pub-id>, PMID: <pub-id pub-id-type="pmid">35029077</pub-id><pub-id pub-id-type="pmcid">PMC8814702</pub-id></mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gill</surname><given-names>SS</given-names></name><name name-style="western"><surname>Roddie</surname><given-names>ME</given-names></name><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>JE</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformations and their mimics</article-title>. <source>Clin Radiol</source>. (<year>2015</year>) <volume>70</volume>:<fpage>96</fpage>&#8211;<lpage>110</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.crad.2014.09.003</pub-id>, PMID: <pub-id pub-id-type="pmid">25443645</pub-id></mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Contegiacomo</surname><given-names>A</given-names></name><name name-style="western"><surname>Del Ciello</surname><given-names>A</given-names></name><name name-style="western"><surname>Rella</surname><given-names>R</given-names></name><name name-style="western"><surname>Attempati</surname><given-names>N</given-names></name><name name-style="western"><surname>Coppolino</surname><given-names>D</given-names></name><name name-style="western"><surname>Larici</surname><given-names>AR</given-names></name><etal/></person-group>. <article-title>Pulmonary arteriovenous malformations: what the interventional radiologist needs to know</article-title>. <source>Radiol Med</source>. (<year>2019</year>) <volume>124</volume>:<fpage>973</fpage>&#8211;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11547-019-01051-7</pub-id>, PMID: <pub-id pub-id-type="pmid">31209790</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cottin</surname><given-names>V</given-names></name><name name-style="western"><surname>Chinet</surname><given-names>T</given-names></name><name name-style="western"><surname>Lavole</surname><given-names>A</given-names></name><name name-style="western"><surname>Corre</surname><given-names>R</given-names></name><name name-style="western"><surname>Marchand</surname><given-names>E</given-names></name><name name-style="western"><surname>Reynaud-Gaubert</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients</article-title>. <source>Medicine</source>. (<year>2007</year>) <volume>86</volume>:<fpage>1</fpage>&#8211;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MD.0b013e31802f8da1</pub-id><pub-id pub-id-type="pmid">17220751</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nawaz</surname><given-names>A</given-names></name><name name-style="western"><surname>Litt</surname><given-names>HI</given-names></name><name name-style="western"><surname>Stavropoulos</surname><given-names>SW</given-names></name><name name-style="western"><surname>Charagundla</surname><given-names>SR</given-names></name><name name-style="western"><surname>Shlansky-Goldberg</surname><given-names>RD</given-names></name><name name-style="western"><surname>Freiman</surname><given-names>DB</given-names></name><etal/></person-group>. <article-title>Digital subtraction pulmonary arteriography versus multidetector CT in the detection of pulmonary arteriovenous malformations</article-title>. <source>J Vasc Interv Radiol</source>. (<year>2008</year>) <volume>19</volume>:<fpage>1582</fpage>&#8211;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvir.2008.07.011</pub-id>, PMID: <pub-id pub-id-type="pmid">18774307</pub-id></mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velthuis</surname><given-names>S</given-names></name><name name-style="western"><surname>Buscarini</surname><given-names>E</given-names></name><name name-style="western"><surname>Mager</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Vorselaars</surname><given-names>VM</given-names></name><name name-style="western"><surname>van Gent</surname><given-names>MW</given-names></name><name name-style="western"><surname>Gazzaniga</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Predicting the size of pulmonary arteriovenous malformations on chest computed tomography: a role for transthoracic contrast echocardiography</article-title>. <source>Eur Respir J</source>. (<year>2014</year>) <volume>44</volume>:<fpage>150</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1183/09031936.00133713</pub-id>, PMID: <pub-id pub-id-type="pmid">24603816</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sha</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Heart-brain axis: association of congenital heart abnormality and brain diseases</article-title>. <source>Front Cardiovasc Med</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1071820</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcvm.2023.1071820</pub-id>, PMID: <pub-id pub-id-type="pmid">37063948</pub-id><pub-id pub-id-type="pmcid">PMC10090520</pub-id></mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lau</surname><given-names>KK</given-names></name><name name-style="western"><surname>Steinke</surname><given-names>K</given-names></name><name name-style="western"><surname>Reis</surname><given-names>S</given-names></name><name name-style="western"><surname>Cherukuri</surname><given-names>SP</given-names></name><name name-style="western"><surname>Cejna</surname><given-names>M</given-names></name></person-group>. <article-title>Current trends in image-guided chest interventions</article-title>. <source>Respirology</source>. (<year>2022</year>) <volume>27</volume>:<fpage>581</fpage>&#8211;<lpage>99</lpage>. doi: <pub-id pub-id-type="doi">10.1111/resp.14315</pub-id>, PMID: <pub-id pub-id-type="pmid">35758539</pub-id><pub-id pub-id-type="pmcid">PMC9545252</pub-id></mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>RI</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Pulmonary arteriovenous malformations: how do I embolize?</article-title><source>Tech Vasc Interv Radiol</source>. (<year>2007</year>) <volume>10</volume>:<fpage>283</fpage>&#8211;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1053/j.tvir.2008.03.007</pub-id><pub-id pub-id-type="pmid">18572143</pub-id></mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>JE</given-names></name><name name-style="western"><surname>Bamford</surname><given-names>KB</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>IH</given-names></name><name name-style="western"><surname>Benjamin</surname><given-names>AR</given-names></name><name name-style="western"><surname>Ramadan</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia</article-title>. <source>Thorax</source>. (<year>2008</year>) <volume>63</volume>:<fpage>259</fpage>&#8211;<lpage>66</lpage>. doi: <pub-id pub-id-type="doi">10.1136/thx.2007.087452</pub-id>, PMID: <pub-id pub-id-type="pmid">17981912</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name><name name-style="western"><surname>Chamali</surname><given-names>B</given-names></name><name name-style="western"><surname>Santhirapala</surname><given-names>V</given-names></name><name name-style="western"><surname>Livesey</surname><given-names>JA</given-names></name><name name-style="western"><surname>Angus</surname><given-names>G</given-names></name><name name-style="western"><surname>Manning</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets</article-title>. <source>PLoS One</source>. (<year>2014</year>) <volume>9</volume>:<fpage>e88812</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0088812</pub-id>, PMID: <pub-id pub-id-type="pmid">24586400</pub-id><pub-id pub-id-type="pmcid">PMC3929507</pub-id></mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maher</surname><given-names>CO</given-names></name><name name-style="western"><surname>Piepgras</surname><given-names>DG</given-names></name><name name-style="western"><surname>Brown</surname><given-names>RD</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Friedman</surname><given-names>JA</given-names></name><name name-style="western"><surname>Pollock</surname><given-names>BE</given-names></name></person-group>. <article-title>Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia</article-title>. <source>Stroke</source>. (<year>2001</year>) <volume>32</volume>:<fpage>877</fpage>&#8211;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.str.32.4.877</pub-id><pub-id pub-id-type="pmid">11283386</pub-id></mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Post</surname><given-names>MC</given-names></name><name name-style="western"><surname>Letteboer</surname><given-names>TG</given-names></name><name name-style="western"><surname>Mager</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Plokker</surname><given-names>TH</given-names></name><name name-style="western"><surname>Kelder</surname><given-names>JC</given-names></name><name name-style="western"><surname>Westermann</surname><given-names>CJ</given-names></name></person-group>. <article-title>A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine</article-title>. <source>Chest</source>. (<year>2005</year>) <volume>128</volume>:<fpage>2485</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.128.4.2485</pub-id>, PMID: <pub-id pub-id-type="pmid">16236913</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name><name name-style="western"><surname>Oh</surname><given-names>YM</given-names></name><name name-style="western"><surname>Shim</surname><given-names>TS</given-names></name><name name-style="western"><surname>Lim</surname><given-names>CM</given-names></name><name name-style="western"><surname>Koh</surname><given-names>YS</given-names></name><etal/></person-group>. <article-title>Clinical characteristics of pulmonary arteriovenous malformations in Koreans</article-title>. <source>Respirology</source>. (<year>2015</year>) <volume>20</volume>:<fpage>155</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1111/resp.12411</pub-id><pub-id pub-id-type="pmid">25289945</pub-id></mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pollak</surname><given-names>JS</given-names></name><name name-style="western"><surname>Saluja</surname><given-names>S</given-names></name><name name-style="western"><surname>Thabet</surname><given-names>A</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Denbow</surname><given-names>N</given-names></name><name name-style="western"><surname>White</surname><given-names>RI</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations</article-title>. <source>J Vasc Interv Radiol</source>. (<year>2006</year>) <volume>17</volume>:<fpage>35</fpage>&#8211;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1097/01.RVI.0000191410.13974.B6</pub-id>, PMID: <pub-id pub-id-type="pmid">16415131</pub-id></mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>JH</given-names></name><name name-style="western"><surname>Park</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Ko</surname><given-names>GY</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>HK</given-names></name><name name-style="western"><surname>Gwon</surname><given-names>DI</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><etal/></person-group>. <article-title>Embolotherapy for pulmonary arteriovenous malformations in patients without hereditary hemorrhagic telangiectasia</article-title>. <source>Korean J Radiol</source>. (<year>2010</year>) <volume>11</volume>:<fpage>312</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.3348/kjr.2010.11.3.312</pub-id>, PMID: <pub-id pub-id-type="pmid">20461185</pub-id><pub-id pub-id-type="pmcid">PMC2864858</pub-id></mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fatania</surname><given-names>G</given-names></name><name name-style="western"><surname>Gilson</surname><given-names>C</given-names></name><name name-style="western"><surname>Glover</surname><given-names>A</given-names></name><name name-style="western"><surname>Alsafi</surname><given-names>A</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>JE</given-names></name><name name-style="western"><surname>Patel</surname><given-names>MC</given-names></name><etal/></person-group>. <article-title>Uptake and radiological findings of screening cerebral magnetic resonance scans in patients with hereditary haemorrhagic telangiectasia</article-title>. <source>Intractable Rare Dis Res</source>. (<year>2018</year>) <volume>7</volume>:<fpage>236</fpage>&#8211;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.5582/irdr.2018.01103</pub-id>, PMID: <pub-id pub-id-type="pmid">30560015</pub-id><pub-id pub-id-type="pmcid">PMC6290842</pub-id></mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kjeldsen</surname><given-names>AD</given-names></name><name name-style="western"><surname>Torring</surname><given-names>PM</given-names></name><name name-style="western"><surname>Nissen</surname><given-names>H</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>PE</given-names></name></person-group>. <article-title>Cerebral abscesses among Danish patients with hereditary haemorrhagic telangiectasia</article-title>. <source>Acta Neurol Scand</source>. (<year>2014</year>) <volume>129</volume>:<fpage>192</fpage>&#8211;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ane.12167</pub-id>, PMID: <pub-id pub-id-type="pmid">23962120</pub-id></mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boother</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Brownlow</surname><given-names>S</given-names></name><name name-style="western"><surname>Tighe</surname><given-names>HC</given-names></name><name name-style="western"><surname>Bamford</surname><given-names>KB</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>JE</given-names></name><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name></person-group>. <article-title>Cerebral abscess associated with odontogenic bacteremias, hypoxemia, and Iron loading in immunocompetent patients with right-to-left shunting through pulmonary arteriovenous malformations</article-title>. <source>Clin Infect Dis</source>. (<year>2017</year>) <volume>65</volume>:<fpage>595</fpage>&#8211;<lpage>603</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cid/cix373</pub-id>, PMID: <pub-id pub-id-type="pmid">28430880</pub-id><pub-id pub-id-type="pmcid">PMC5849101</pub-id></mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velthuis</surname><given-names>S</given-names></name><name name-style="western"><surname>Buscarini</surname><given-names>E</given-names></name><name name-style="western"><surname>van Gent</surname><given-names>MWF</given-names></name><name name-style="western"><surname>Gazzaniga</surname><given-names>P</given-names></name><name name-style="western"><surname>Manfredi</surname><given-names>G</given-names></name><name name-style="western"><surname>Danesino</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Grade of pulmonary right-to-left shunt on contrast echocardiography and cerebral complications: a striking association</article-title>. <source>Chest</source>. (<year>2013</year>) <volume>144</volume>:<fpage>542</fpage>&#8211;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.12-1599</pub-id>, PMID: <pub-id pub-id-type="pmid">23429940</pub-id></mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mager</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Overtoom</surname><given-names>TT</given-names></name><name name-style="western"><surname>Blauw</surname><given-names>H</given-names></name><name name-style="western"><surname>Lammers</surname><given-names>JW</given-names></name><name name-style="western"><surname>Westermann</surname><given-names>CJ</given-names></name></person-group>. <article-title>Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients</article-title>. <source>J Vasc Interv Radiol</source>. (<year>2004</year>) <volume>15</volume>:<fpage>451</fpage>&#8211;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1097/01.rvi.0000126811.05229.b6</pub-id>, PMID: <pub-id pub-id-type="pmid">15126654</pub-id></mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albitar</surname><given-names>HAH</given-names></name><name name-style="western"><surname>Segraves</surname><given-names>JM</given-names></name><name name-style="western"><surname>Almodallal</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pinto</surname><given-names>CA</given-names></name><name name-style="western"><surname>De Moraes</surname><given-names>AG</given-names></name><name name-style="western"><surname>Iyer</surname><given-names>VN</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformations in non-hereditary hemorrhagic telangiectasia patients: an 18-year retrospective study</article-title>. <source>Lung</source>. (<year>2020</year>) <volume>198</volume>:<fpage>679</fpage>&#8211;<lpage>86</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00408-020-00367-w</pub-id><pub-id pub-id-type="pmid">32648120</pub-id></mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Angriman</surname><given-names>F</given-names></name><name name-style="western"><surname>Ferreyro</surname><given-names>BL</given-names></name><name name-style="western"><surname>Wainstein</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Serra</surname><given-names>MM</given-names></name></person-group>. <article-title>Malformaciones arteriovenosas pulmonares y complicaciones emb&#243;licas en pacientes con telangiectasia hemorr&#225;gica hereditaria</article-title>. <source>Arch Bronconeumol</source>. (<year>2014</year>) <volume>50</volume>:<fpage>301</fpage>&#8211;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arbres.2013.08.006</pub-id>, PMID: <pub-id pub-id-type="pmid">24629762</pub-id></mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faughnan</surname><given-names>ME</given-names></name><name name-style="western"><surname>Lui</surname><given-names>YW</given-names></name><name name-style="western"><surname>Wirth</surname><given-names>JA</given-names></name><name name-style="western"><surname>Pugash</surname><given-names>RA</given-names></name><name name-style="western"><surname>Redelmeier</surname><given-names>DA</given-names></name><name name-style="western"><surname>Hyland</surname><given-names>RH</given-names></name><etal/></person-group>. <article-title>Diffuse pulmonary arteriovenous malformations: characteristics and prognosis</article-title>. <source>Chest</source>. (<year>2000</year>) <volume>117</volume>:<fpage>31</fpage>&#8211;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.117.1.31</pub-id><pub-id pub-id-type="pmid">10631195</pub-id></mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Na</surname><given-names>YO</given-names></name><name name-style="western"><surname>Park</surname><given-names>HK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JK</given-names></name><name name-style="western"><surname>Kho</surname><given-names>BG</given-names></name><name name-style="western"><surname>Kim</surname><given-names>TO</given-names></name><name name-style="western"><surname>Shin</surname><given-names>HJ</given-names></name><etal/></person-group>. <article-title>Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: a multicenter retrospective cohort study</article-title>. <source>PLoS One</source>. (<year>2022</year>) <volume>17</volume>:<fpage>e0278610</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0278610</pub-id>, PMID: <pub-id pub-id-type="pmid">36454973</pub-id><pub-id pub-id-type="pmcid">PMC9714939</pub-id></mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pierucci</surname><given-names>P</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>J</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Chyun</surname><given-names>DA</given-names></name><name name-style="western"><surname>White</surname><given-names>RI</given-names><suffix>Jr</suffix></name></person-group>. <article-title>New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty-seven-year experience</article-title>. <source>Chest</source>. (<year>2008</year>) <volume>133</volume>:<fpage>653</fpage>&#8211;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.07-1949</pub-id>, PMID: <pub-id pub-id-type="pmid">18198252</pub-id></mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kroon</surname><given-names>S</given-names></name><name name-style="western"><surname>van den Heuvel</surname><given-names>DAF</given-names></name><name name-style="western"><surname>Vos</surname><given-names>JA</given-names></name><name name-style="western"><surname>van Leersum</surname><given-names>M</given-names></name><name name-style="western"><surname>van Strijen</surname><given-names>MJL</given-names></name><name name-style="western"><surname>Post</surname><given-names>MC</given-names></name><etal/></person-group>. <article-title>Idiopathic and hereditary haemorrhagic telangiectasia associated pulmonary arteriovenous malformations: comparison of clinical and radiographic characteristics</article-title>. <source>Clin Radiol</source>. (<year>2021</year>) <volume>76</volume>:<fpage>394.e1</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.crad.2021.01.011</pub-id>, PMID: <pub-id pub-id-type="pmid">33648759</pub-id></mixed-citation></ref><ref id="ref47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>S</given-names></name><name name-style="western"><surname>Lim</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Chung</surname><given-names>YG</given-names></name><name name-style="western"><surname>Cho</surname><given-names>TH</given-names></name><name name-style="western"><surname>Lim</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>WJ</given-names></name><etal/></person-group>. <article-title>The multiple brain abscesses associated with congenital pulmonary arteriovenous malformations: a case report</article-title>. <source>J Korean Med Sci</source>. (<year>2002</year>) <volume>17</volume>:<fpage>407</fpage>&#8211;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.3346/jkms.2002.17.3.407</pub-id>, PMID: <pub-id pub-id-type="pmid">12068149</pub-id><pub-id pub-id-type="pmcid">PMC3054878</pub-id></mixed-citation></ref><ref id="ref48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kernan</surname><given-names>WN</given-names></name><name name-style="western"><surname>Ovbiagele</surname><given-names>B</given-names></name><name name-style="western"><surname>Black</surname><given-names>HR</given-names></name><name name-style="western"><surname>Bravata</surname><given-names>DM</given-names></name><name name-style="western"><surname>Chimowitz</surname><given-names>MI</given-names></name><name name-style="western"><surname>Ezekowitz</surname><given-names>MD</given-names></name><etal/></person-group>. <article-title>Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association</article-title>. <source>Stroke</source>. (<year>2014</year>) <volume>45</volume>:<fpage>2160</fpage>&#8211;<lpage>236</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STR.0000000000000024</pub-id><pub-id pub-id-type="pmid">24788967</pub-id></mixed-citation></ref><ref id="ref49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unger</surname><given-names>P</given-names></name><name name-style="western"><surname>Stoupel</surname><given-names>E</given-names></name><name name-style="western"><surname>Shadfar</surname><given-names>S</given-names></name><name name-style="western"><surname>Pandolfo</surname><given-names>M</given-names></name><name name-style="western"><surname>Blecic</surname><given-names>S</given-names></name></person-group>. <article-title>Recurrent transient ischemic attacks in a patient with intrapulmonary arteriovenous shunting detected after closure of a patent foramen ovale</article-title>. <source>J Am Soc Echocardiogr</source>. (<year>2004</year>) <volume>17</volume>:<fpage>775</fpage>&#8211;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.echo.2004.02.014</pub-id><pub-id pub-id-type="pmid">15220904</pub-id></mixed-citation></ref><ref id="ref50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Topiwala</surname><given-names>KK</given-names></name><name name-style="western"><surname>Patel</surname><given-names>SD</given-names></name><name name-style="western"><surname>Pervez</surname><given-names>M</given-names></name><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name><name name-style="western"><surname>Alberts</surname><given-names>MJ</given-names></name></person-group>. <article-title>Ischemic stroke in patients with pulmonary arteriovenous fistulas</article-title>. <source>Stroke</source>. (<year>2021</year>) <volume>52</volume>:<fpage>e311</fpage>&#8211;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.120.032073</pub-id>, PMID: <pub-id pub-id-type="pmid">34082575</pub-id></mixed-citation></ref><ref id="ref51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fanning</surname><given-names>JP</given-names></name><name name-style="western"><surname>Wesley</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Wong</surname><given-names>AA</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>JF</given-names></name></person-group>. <article-title>Emerging spectra of silent brain infarction</article-title>. <source>Stroke</source>. (<year>2014</year>) <volume>45</volume>:<fpage>3461</fpage>&#8211;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.114.005919</pub-id>, PMID: <pub-id pub-id-type="pmid">25293663</pub-id></mixed-citation></ref><ref id="ref52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Putaala</surname><given-names>J</given-names></name><name name-style="western"><surname>Haapaniemi</surname><given-names>E</given-names></name><name name-style="western"><surname>Kurkinen</surname><given-names>M</given-names></name><name name-style="western"><surname>Salonen</surname><given-names>O</given-names></name><name name-style="western"><surname>Kaste</surname><given-names>M</given-names></name><name name-style="western"><surname>Tatlisumak</surname><given-names>T</given-names></name></person-group>. <article-title>Silent brain infarcts, leukoaraiosis, and long-term prognosis in young ischemic stroke patients</article-title>. <source>Neurology</source>. (<year>2011</year>) <volume>76</volume>:<fpage>1742</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0b013e31821a44ad</pub-id>, PMID: <pub-id pub-id-type="pmid">21576692</pub-id></mixed-citation></ref><ref id="ref53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinjikji</surname><given-names>W</given-names></name><name name-style="western"><surname>Nasr</surname><given-names>DM</given-names></name><name name-style="western"><surname>Wood</surname><given-names>CP</given-names></name><name name-style="western"><surname>Iyer</surname><given-names>VN</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformations are associated with silent brain infarcts in hereditary hemorrhagic telangiectasia patients</article-title>. <source>Cerebrovasc Dis</source>. (<year>2017</year>) <volume>44</volume>:<fpage>179</fpage>&#8211;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000478734</pub-id>, PMID: <pub-id pub-id-type="pmid">28746925</pub-id></mixed-citation></ref><ref id="ref54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Shin</surname><given-names>HY</given-names></name><name name-style="western"><surname>Ha</surname><given-names>YS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JW</given-names></name><name name-style="western"><surname>Kang</surname><given-names>KW</given-names></name><name name-style="western"><surname>Na</surname><given-names>DL</given-names></name><etal/></person-group>. <article-title>Paradoxical embolism as a cause of silent brain infarctions in healthy subjects: the ICONS study (identification of the cause of silent cerebral infarction in healthy subjects)</article-title>. <source>Eur J Neurol</source>. (<year>2013</year>) <volume>20</volume>:<fpage>353</fpage>&#8211;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1468-1331.2012.03864.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22958084</pub-id></mixed-citation></ref><ref id="ref55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furie</surname><given-names>KL</given-names></name><name name-style="western"><surname>Kasner</surname><given-names>SE</given-names></name><name name-style="western"><surname>Adams</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Albers</surname><given-names>GW</given-names></name><name name-style="western"><surname>Bush</surname><given-names>RL</given-names></name><name name-style="western"><surname>Fagan</surname><given-names>SC</given-names></name><etal/></person-group>. <article-title>Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association</article-title>. <source>Stroke</source>. (<year>2011</year>) <volume>42</volume>:<fpage>227</fpage>&#8211;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STR.0b013e3181f7d043</pub-id><pub-id pub-id-type="pmid">20966421</pub-id></mixed-citation></ref><ref id="ref56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Devlin</surname><given-names>HL</given-names></name><name name-style="western"><surname>Hosman</surname><given-names>AE</given-names></name><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name></person-group>. <article-title>Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia</article-title>. <source>N Engl J Med</source>. (<year>2013</year>) <volume>368</volume>, <volume>9</volume>:<fpage>876</fpage>&#8211;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMc1213554</pub-id><pub-id pub-id-type="pmid">23445111</pub-id></mixed-citation></ref><ref id="ref57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>B</given-names></name><name name-style="western"><surname>Ewert</surname><given-names>P</given-names></name><name name-style="western"><surname>Schubert</surname><given-names>S</given-names></name><name name-style="western"><surname>Abdul-Khaliq</surname><given-names>H</given-names></name><name name-style="western"><surname>Lange</surname><given-names>PE</given-names></name></person-group>. <article-title>Rare case of pulmonary arteriovenous fistula simulating residual defect after transcatheter closure of patent foramen ovale for recurrent paradoxical embolism</article-title>. <source>Catheter Cardiovasc Interv</source>. (<year>2005</year>) <volume>64</volume>:<fpage>348</fpage>&#8211;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ccd.20293</pub-id>, PMID: <pub-id pub-id-type="pmid">15736259</pub-id></mixed-citation></ref><ref id="ref58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kijima</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rafique</surname><given-names>AM</given-names></name><name name-style="western"><surname>Tobis</surname><given-names>JM</given-names></name></person-group>. <article-title>Patent foramen ovale combined with pulmonary arteriovenous malformation</article-title>. <source>JACC Cardiovasc Interv</source>. (<year>2016</year>) <volume>9</volume>:<fpage>2169</fpage>&#8211;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcin.2016.08.020</pub-id>, PMID: <pub-id pub-id-type="pmid">27765314</pub-id></mixed-citation></ref><ref id="ref59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Topiwala</surname><given-names>KK</given-names></name><name name-style="western"><surname>Patel</surname><given-names>SD</given-names></name><name name-style="western"><surname>Saver</surname><given-names>JL</given-names></name><name name-style="western"><surname>Streib</surname><given-names>CD</given-names></name><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name></person-group>. <article-title>Ischemic stroke and pulmonary arteriovenous malformations: a review</article-title>. <source>Neurology</source>. (<year>2022</year>) <volume>98</volume>:<fpage>188</fpage>&#8211;<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0000000000013169</pub-id><pub-id pub-id-type="pmid">34880092</pub-id><pub-id pub-id-type="pmcid">PMC8826462</pub-id></mixed-citation></ref><ref id="ref60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name><name name-style="western"><surname>Dong</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name><name name-style="western"><surname>Sun</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name></person-group>. <article-title>Unusual synchronous liver and brain abscesses infected by rare Aerococcus viridians in a patient with pulmonary arteriovenous malformations on FDG PET/CT: a case report and literature review</article-title>. <source>Medicine</source>. (<year>2017</year>) <volume>96</volume>:<fpage>e9048</fpage>. doi: <pub-id pub-id-type="doi">10.1097/MD.0000000000009048</pub-id>, PMID: <pub-id pub-id-type="pmid">29245306</pub-id><pub-id pub-id-type="pmcid">PMC5728921</pub-id></mixed-citation></ref><ref id="ref61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thanopoulos</surname><given-names>BV</given-names></name><name name-style="western"><surname>Papaioannou</surname><given-names>G</given-names></name></person-group>. <article-title>Catheter occlusion of a pulmonary arteriovenous fistula in a patient 65 years old with paradoxical ischemic stroke: 2-year follow-up</article-title>. <source>JACC Cardiovasc Interv</source>. (<year>2014</year>) <volume>7</volume>:<fpage>e113</fpage>&#8211;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcin.2014.01.178</pub-id>, PMID: <pub-id pub-id-type="pmid">25234685</pub-id></mixed-citation></ref><ref id="ref62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilmshurst</surname><given-names>PT</given-names></name><name name-style="western"><surname>Nightingale</surname><given-names>S</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>KP</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>WL</given-names></name></person-group>. <article-title>Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons</article-title>. <source>Lancet</source>. (<year>2000</year>) <volume>356</volume>:<fpage>1648</fpage>&#8211;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0140-6736(00)03160-3</pub-id><pub-id pub-id-type="pmid">11089825</pub-id></mixed-citation></ref><ref id="ref63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W</given-names></name><name name-style="western"><surname>Lan</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>The value of contrast-enhanced transesophageal echocardiography in the detection of cardiac right-to-left shunt related with cryptogenic stroke and migraine</article-title>. <source>Biomed Res Int</source>. (<year>2020</year>) <volume>2020</volume>:<fpage>8845652</fpage>&#8211;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2020/8845652</pub-id>, PMID: <pub-id pub-id-type="pmid">33415164</pub-id><pub-id pub-id-type="pmcid">PMC7752281</pub-id></mixed-citation></ref><ref id="ref64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilmshurst</surname><given-names>P</given-names></name><name name-style="western"><surname>Nightingale</surname><given-names>S</given-names></name></person-group>. <article-title>The role of cardiac and pulmonary pathology in migraine: a hypothesis</article-title>. <source>Headache</source>. (<year>2006</year>) <volume>46</volume>:<fpage>429</fpage>&#8211;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00374.x</pub-id><pub-id pub-id-type="pmid">16618259</pub-id></mixed-citation></ref><ref id="ref65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kakehi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>N</given-names></name><name name-style="western"><surname>Miyazaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>H</given-names></name><name name-style="western"><surname>Nagami</surname><given-names>S</given-names></name><name name-style="western"><surname>Kohyama</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>A patient with pulmonary arteriovenous fistulas (P-AVFs) in whom migraine disappeared after transcatheter coil embolization for the secondary prevention of paradoxical infarction. A case report</article-title>. <source>Cephalalgia</source>. (<year>2017</year>) <volume>37</volume>:<fpage>294</fpage>&#8211;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0333102416644434</pub-id>, PMID: <pub-id pub-id-type="pmid">27067920</pub-id></mixed-citation></ref><ref id="ref66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bateman</surname><given-names>DN</given-names></name></person-group>. <article-title>Triptans and migraine</article-title>. <source>Lancet</source>. (<year>2000</year>) <volume>355</volume>:<fpage>860</fpage>&#8211;<lpage>1</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(00)90028-X</pub-id><pub-id pub-id-type="pmid">10752697</pub-id></mixed-citation></ref><ref id="ref67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrari</surname><given-names>MD</given-names></name><name name-style="western"><surname>Goadsby</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Burstein</surname><given-names>R</given-names></name><name name-style="western"><surname>Kurth</surname><given-names>T</given-names></name><name name-style="western"><surname>Ayata</surname><given-names>C</given-names></name><name name-style="western"><surname>Charles</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Migraine</article-title>. <source>Nat Rev Dis Primers</source>. (<year>2022</year>) <volume>8</volume>:<fpage>2</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41572-021-00328-4</pub-id><pub-id pub-id-type="pmid">35027572</pub-id></mixed-citation></ref><ref id="ref68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kakeshita</surname><given-names>K</given-names></name><name name-style="western"><surname>Yoneda</surname><given-names>T</given-names></name><name name-style="western"><surname>Koba</surname><given-names>H</given-names></name><name name-style="western"><surname>Tanimura</surname><given-names>K</given-names></name><name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name><name name-style="western"><surname>Kaneda</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Case report: migraine that persisted for over 20 years disappears after treatment for pulmonary arteriovenous fistula</article-title>. <source>Clin Case Rep</source>. (<year>2020</year>) <volume>8</volume>:<fpage>1872</fpage>&#8211;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ccr3.3037</pub-id>, PMID: <pub-id pub-id-type="pmid">33088509</pub-id><pub-id pub-id-type="pmcid">PMC7562846</pub-id></mixed-citation></ref><ref id="ref69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onorato</surname><given-names>EM</given-names></name><name name-style="western"><surname>Salvia</surname><given-names>J</given-names></name><name name-style="western"><surname>Becchina</surname><given-names>M</given-names></name><name name-style="western"><surname>Cipolla</surname><given-names>T</given-names></name><name name-style="western"><surname>Anzola</surname><given-names>GP</given-names></name></person-group>. <article-title>Can aura migraine be elicited by isolated pulmonary arteriovenous fistula?-A case report</article-title>. <source>Front Neurol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>1079959</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fneur.2022.1079959</pub-id>, PMID: <pub-id pub-id-type="pmid">36588875</pub-id><pub-id pub-id-type="pmcid">PMC9797860</pub-id></mixed-citation></ref><ref id="ref70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adelborg</surname><given-names>K</given-names></name><name name-style="western"><surname>Szepligeti</surname><given-names>SK</given-names></name><name name-style="western"><surname>Holland-Bill</surname><given-names>L</given-names></name><name name-style="western"><surname>Ehrenstein</surname><given-names>V</given-names></name><name name-style="western"><surname>Horvath-Puho</surname><given-names>E</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>VW</given-names></name><etal/></person-group>. <article-title>Migraine and risk of cardiovascular diseases: Danish population based matched cohort study</article-title>. <source>BMJ</source>. (<year>2018</year>) <volume>360</volume>:<fpage>k96</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj.k96</pub-id>, PMID: <pub-id pub-id-type="pmid">29386181</pub-id><pub-id pub-id-type="pmcid">PMC5791041</pub-id></mixed-citation></ref><ref id="ref71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name></person-group>. <article-title>Characteristics and analysis of right-to-left shunt-related dizziness in patients without hypoxemia</article-title>. <source>J Int Med Res</source>. (<year>2019</year>) <volume>47</volume>:<fpage>2921</fpage>&#8211;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0300060519850940</pub-id>, PMID: <pub-id pub-id-type="pmid">31130028</pub-id><pub-id pub-id-type="pmcid">PMC6683883</pub-id></mixed-citation></ref><ref id="ref72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sladden</surname><given-names>D</given-names></name><name name-style="western"><surname>Casha</surname><given-names>A</given-names></name><name name-style="western"><surname>Azzopardi</surname><given-names>C</given-names></name><name name-style="western"><surname>Manch&#233;</surname><given-names>A</given-names></name></person-group>. <article-title>A large pulmonary arteriovenous malformation causing cerebrovascular accidents</article-title>. <source>BMJ Case Rep</source>. (<year>2015</year>) <volume>2015</volume>:<fpage>bcr2014207786</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bcr-2014-207786</pub-id>, PMID: <pub-id pub-id-type="pmid">25883250</pub-id><pub-id pub-id-type="pmcid">PMC4401929</pub-id></mixed-citation></ref><ref id="ref73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>KH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>GY</given-names></name><name name-style="western"><surname>Song</surname><given-names>W</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformations presenting as refractory heart failure</article-title>. <source>J Thorac Dis</source>. (<year>2014</year>) <volume>6</volume>:<fpage>E169</fpage>&#8211;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.3978/j.issn.2072-1439.2014.07.39</pub-id>, PMID: <pub-id pub-id-type="pmid">25276390</pub-id><pub-id pub-id-type="pmcid">PMC4178099</pub-id></mixed-citation></ref><ref id="ref74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faughnan</surname><given-names>ME</given-names></name><name name-style="western"><surname>Granton</surname><given-names>JT</given-names></name><name name-style="western"><surname>Young</surname><given-names>LH</given-names></name></person-group>. <article-title>The pulmonary vascular complications of hereditary haemorrhagic telangiectasia</article-title>. <source>Eur Respir J</source>. (<year>2009</year>) <volume>33</volume>:<fpage>1186</fpage>&#8211;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1183/09031936.00061308</pub-id><pub-id pub-id-type="pmid">19407052</pub-id></mixed-citation></ref><ref id="ref75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vonk-Noordegraaf</surname><given-names>A</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>F</given-names></name><name name-style="western"><surname>Chin</surname><given-names>KM</given-names></name><name name-style="western"><surname>Forfia</surname><given-names>PR</given-names></name><name name-style="western"><surname>Kawut</surname><given-names>SM</given-names></name><name name-style="western"><surname>Lumens</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology</article-title>. <source>J Am Coll Cardiol</source>. (<year>2013</year>) <volume>62</volume>:<fpage>D22</fpage>&#8211;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacc.2013.10.027</pub-id><pub-id pub-id-type="pmid">24355638</pub-id></mixed-citation></ref><ref id="ref76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farhan</surname><given-names>A</given-names></name><name name-style="western"><surname>Latif</surname><given-names>MA</given-names></name><name name-style="western"><surname>Minhas</surname><given-names>A</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>CR</given-names></name></person-group>. <article-title>Cardiac and hemodynamic manifestations of hereditary hemorrhagic telangiectasia</article-title>. <source>Int J Angiol</source>. (<year>2022</year>) <volume>31</volume>:<fpage>75</fpage>&#8211;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-0042-1745842</pub-id>, PMID: <pub-id pub-id-type="pmid">35923582</pub-id><pub-id pub-id-type="pmcid">PMC9341259</pub-id></mixed-citation></ref><ref id="ref77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name><name name-style="western"><surname>Tighe</surname><given-names>HC</given-names></name><name name-style="western"><surname>Davies</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Gibbs</surname><given-names>JS</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>JE</given-names></name></person-group>. <article-title>Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure</article-title>. <source>Eur Respir J</source>. (<year>2008</year>) <volume>32</volume>:<fpage>162</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1183/09031936.00126207</pub-id>, PMID: <pub-id pub-id-type="pmid">18385173</pub-id></mixed-citation></ref><ref id="ref78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santhirapala</surname><given-names>V</given-names></name><name name-style="western"><surname>Chamali</surname><given-names>B</given-names></name><name name-style="western"><surname>McKernan</surname><given-names>H</given-names></name><name name-style="western"><surname>Tighe</surname><given-names>HC</given-names></name><name name-style="western"><surname>Williams</surname><given-names>LC</given-names></name><name name-style="western"><surname>Springett</surname><given-names>JT</given-names></name><etal/></person-group>. <article-title>Orthodeoxia and postural orthostatic tachycardia in patients with pulmonary arteriovenous malformations: a prospective 8-year series</article-title>. <source>Thorax</source>. (<year>2014</year>) <volume>69</volume>:<fpage>1046</fpage>&#8211;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1136/thoraxjnl-2014-205289</pub-id>, PMID: <pub-id pub-id-type="pmid">24713588</pub-id></mixed-citation></ref><ref id="ref79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>K</given-names></name><name name-style="western"><surname>Pyeritz</surname><given-names>RE</given-names></name><name name-style="western"><surname>Trerotola</surname><given-names>SO</given-names></name></person-group>. <article-title>Angina pectoris or myocardial infarctions, pulmonary arteriovenous malformations, hereditary hemorrhagic telangiectasia, and paradoxical emboli</article-title>. <source>Am J Cardiol</source>. (<year>2013</year>) <volume>112</volume>:<fpage>731</fpage>&#8211;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.amjcard.2013.04.052</pub-id><pub-id pub-id-type="pmid">23707042</pub-id></mixed-citation></ref><ref id="ref80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kavarana</surname><given-names>MN</given-names></name><name name-style="western"><surname>Jones</surname><given-names>JA</given-names></name><name name-style="western"><surname>Stroud</surname><given-names>RE</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>SM</given-names></name><name name-style="western"><surname>Ikonomidis</surname><given-names>JS</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>R</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications</article-title>. <source>Expert Rev Cardiovasc Ther</source>. (<year>2014</year>) <volume>12</volume>:<fpage>703</fpage>&#8211;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1586/14779072.2014.912132</pub-id><pub-id pub-id-type="pmid">24758411</pub-id><pub-id pub-id-type="pmcid">PMC4410694</pub-id></mixed-citation></ref><ref id="ref81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>L</given-names></name><name name-style="western"><surname>Santhirapala</surname><given-names>V</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>K</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>B</given-names></name><name name-style="western"><surname>Busbridge</surname><given-names>M</given-names></name><name name-style="western"><surname>Tighe</surname><given-names>HC</given-names></name><etal/></person-group>. <article-title>Cardiopulmonary exercise testing demonstrates maintenance of exercise capacity in patients with hypoxemia and pulmonary arteriovenous malformations</article-title>. <source>Chest</source>. (<year>2014</year>) <volume>146</volume>:<fpage>709</fpage>&#8211;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.13-2988</pub-id>, PMID: <pub-id pub-id-type="pmid">24676541</pub-id></mixed-citation></ref><ref id="ref82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lacombe</surname><given-names>P</given-names></name><name name-style="western"><surname>Lacout</surname><given-names>A</given-names></name><name name-style="western"><surname>Marcy</surname><given-names>PY</given-names></name><name name-style="western"><surname>Binsse</surname><given-names>S</given-names></name><name name-style="western"><surname>Sellier</surname><given-names>J</given-names></name><name name-style="western"><surname>Bensalah</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: an overview</article-title>. <source>Diagn Interv Imaging</source>. (<year>2013</year>) <volume>94</volume>:<fpage>835</fpage>&#8211;<lpage>48</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.diii.2013.03.014</pub-id>, PMID: <pub-id pub-id-type="pmid">23763987</pub-id></mixed-citation></ref><ref id="ref83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santhirapala</surname><given-names>V</given-names></name><name name-style="western"><surname>Williams</surname><given-names>LC</given-names></name><name name-style="western"><surname>Tighe</surname><given-names>HC</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>JE</given-names></name><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name></person-group>. <article-title>Arterial oxygen content is precisely maintained by graded erythrocytotic responses in settings of high/normal serum iron levels, and predicts exercise capacity: an observational study of hypoxaemic patients with pulmonary arteriovenous malformations</article-title>. <source>PLoS One</source>. (<year>2014</year>) <volume>9</volume>:<fpage>e90777</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0090777</pub-id>, PMID: <pub-id pub-id-type="pmid">24637882</pub-id><pub-id pub-id-type="pmcid">PMC3956463</pub-id></mixed-citation></ref><ref id="ref84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salibe-Filho</surname><given-names>W</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>FR</given-names></name><name name-style="western"><surname>Terra-Filho</surname><given-names>M</given-names></name></person-group>. <article-title>Update on pulmonary arteriovenous malformations</article-title>. <source>J Bras Pneumol</source>. (<year>2023</year>) <volume>49</volume>:<fpage>e20220359</fpage>. doi: <pub-id pub-id-type="doi">10.36416/1806-3756/e20220359</pub-id>, PMID: <pub-id pub-id-type="pmid">37132738</pub-id><pub-id pub-id-type="pmcid">PMC10171268</pub-id></mixed-citation></ref><ref id="ref85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milic</surname><given-names>A</given-names></name><name name-style="western"><surname>Chan</surname><given-names>RP</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>JH</given-names></name><name name-style="western"><surname>Faughnan</surname><given-names>ME</given-names></name></person-group>. <article-title>Reperfusion of pulmonary arteriovenous malformations after embolotherapy</article-title>. <source>J Vasc Interv Radiol</source>. (<year>2005</year>) <volume>16</volume>:<fpage>1675</fpage>&#8211;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1097/01.RVI.0000182163.25493.BB</pub-id><pub-id pub-id-type="pmid">16371535</pub-id></mixed-citation></ref><ref id="ref86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Qin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name></person-group>. <article-title>Rare ruptured pulmonary arteriovenous malformation mimicking lung tumor in a girl</article-title>. <source>Anatol J Cardiol</source>. (<year>2021</year>) <volume>25</volume>:<fpage>5030</fpage>. doi: <pub-id pub-id-type="doi">10.5152/AnatolJCardiol.2021.74790</pub-id>, PMID: <pub-id pub-id-type="pmid">34236335</pub-id><pub-id pub-id-type="pmcid">PMC8274894</pub-id></mixed-citation></ref><ref id="ref87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elmali</surname><given-names>M</given-names></name><name name-style="western"><surname>Akan</surname><given-names>H</given-names></name><name name-style="western"><surname>Findik</surname><given-names>S</given-names></name><name name-style="western"><surname>Kale</surname><given-names>M</given-names></name><name name-style="western"><surname>Celenk</surname><given-names>C</given-names></name></person-group>. <article-title>Hereditary hemorrhagic telangiectasia associated with pulmonary arteriovenous malformations presenting as hemothorax</article-title>. <source>J Thorac Imaging</source>. (<year>2008</year>) <volume>23</volume>:<fpage>295</fpage>&#8211;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1097/RTI.0b013e3181820867</pub-id>, PMID: <pub-id pub-id-type="pmid">19204479</pub-id></mixed-citation></ref><ref id="ref88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ference</surname><given-names>BA</given-names></name><name name-style="western"><surname>Shannon</surname><given-names>TM</given-names></name><name name-style="western"><surname>White</surname><given-names>RI</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Zawin</surname><given-names>M</given-names></name><name name-style="western"><surname>Burdge</surname><given-names>CM</given-names></name></person-group>. <article-title>Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia</article-title>. <source>Chest</source>. (<year>1994</year>) <volume>106</volume>:<fpage>1387</fpage>&#8211;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.106.5.1387</pub-id><pub-id pub-id-type="pmid">7956388</pub-id></mixed-citation></ref><ref id="ref89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montani</surname><given-names>D</given-names></name><name name-style="western"><surname>Price</surname><given-names>LC</given-names></name><name name-style="western"><surname>Girerd</surname><given-names>B</given-names></name><name name-style="western"><surname>Chinet</surname><given-names>T</given-names></name><name name-style="western"><surname>Lacombe</surname><given-names>P</given-names></name><name name-style="western"><surname>Simonneau</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH</article-title>. <source>Eur Respir Rev</source>. (<year>2009</year>) <volume>18</volume>:<fpage>42</fpage>&#8211;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1183/09059180.00011113</pub-id><pub-id pub-id-type="pmid">20956122</pub-id></mixed-citation></ref><ref id="ref90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>R</given-names></name><name name-style="western"><surname>Gong</surname><given-names>SG</given-names></name><name name-style="western"><surname>Pudasaini</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>QH</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Diffuse pulmonary arteriovenous fistulas with pulmonary arterial hypertension: case report and review</article-title>. <source>Medicine</source>. (<year>2016</year>) <volume>95</volume>:<fpage>e3177</fpage>. doi: <pub-id pub-id-type="doi">10.1097/MD.0000000000003177</pub-id><pub-id pub-id-type="pmid">27057843</pub-id><pub-id pub-id-type="pmcid">PMC4998759</pub-id></mixed-citation></ref><ref id="ref91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shovlin</surname><given-names>CL</given-names></name><name name-style="western"><surname>Sodhi</surname><given-names>V</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>A</given-names></name><name name-style="western"><surname>Lasjaunias</surname><given-names>P</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>JE</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>MN</given-names></name></person-group>. <article-title>Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler&#8211;Weber&#8211;Rendu syndrome): suggested approach for obstetric services</article-title>. <source>BJOG</source>. (<year>2008</year>) <volume>115</volume>:<fpage>1108</fpage>&#8211;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1471-0528.2008.01786.x</pub-id><pub-id pub-id-type="pmid">18518871</pub-id></mixed-citation></ref><ref id="ref92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jutant</surname><given-names>EM</given-names></name><name name-style="western"><surname>Puyo</surname><given-names>P</given-names></name><name name-style="western"><surname>El Hajjam</surname><given-names>M</given-names></name><name name-style="western"><surname>Blivet</surname><given-names>S</given-names></name><name name-style="western"><surname>Houdart</surname><given-names>E</given-names></name><name name-style="western"><surname>Aubier</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Severe, chronic cough caused by pulmonary arteriovenous malformations in a patient with hereditary haemorrhagic telangiectasia: case report</article-title>. <source>BMC Pulm Med</source>. (<year>2015</year>) <volume>15</volume>:<fpage>28</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12890-015-0024-0</pub-id><pub-id pub-id-type="pmid">25887242</pub-id><pub-id pub-id-type="pmcid">PMC4380104</pub-id></mixed-citation></ref><ref id="ref93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nusca</surname><given-names>A</given-names></name><name name-style="western"><surname>Viscusi</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ussia</surname><given-names>GP</given-names></name></person-group>. <article-title>Double anterograde/retrograde approach for embolization of pulmonary arteriovenous malformation presenting with acute respiratory failure</article-title>. <source>Eur Heart J</source>. (<year>2023</year>) <volume>44</volume>:<fpage>2348</fpage>. doi: <pub-id pub-id-type="doi">10.1093/eurheartj/ehad071</pub-id>, PMID: <pub-id pub-id-type="pmid">36806935</pub-id></mixed-citation></ref><ref id="ref94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naito</surname><given-names>J</given-names></name><name name-style="western"><surname>Kasai</surname><given-names>H</given-names></name><name name-style="western"><surname>Suga</surname><given-names>M</given-names></name><name name-style="western"><surname>Sugiura</surname><given-names>T</given-names></name><name name-style="western"><surname>Tanabe</surname><given-names>N</given-names></name><name name-style="western"><surname>Tatsumi</surname><given-names>K</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformations complicated by splenic infarction and abscess</article-title>. <source>Respirol Case Rep</source>. (<year>2017</year>) <volume>5</volume>:<fpage>e00254</fpage>. doi: <pub-id pub-id-type="doi">10.1002/rcr2.254</pub-id>, PMID: <pub-id pub-id-type="pmid">28736615</pub-id><pub-id pub-id-type="pmcid">PMC5518768</pub-id></mixed-citation></ref><ref id="ref95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brothers</surname><given-names>M</given-names></name><name name-style="western"><surname>Peeler</surname><given-names>B</given-names></name><name name-style="western"><surname>Paolillo</surname><given-names>J</given-names></name></person-group>. <article-title>Renal thromboembolism from a large pulmonary artery to a pulmonary vein fistula in an asymptomatic adolescent</article-title>. <source>Cardiol Young</source>. (<year>2017</year>) <volume>27</volume>:<fpage>199</fpage>&#8211;<lpage>201</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S1047951116001165</pub-id>, PMID: <pub-id pub-id-type="pmid">27641361</pub-id></mixed-citation></ref><ref id="ref96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marks</surname><given-names>JA</given-names></name><name name-style="western"><surname>Martin</surname><given-names>ND</given-names></name><name name-style="western"><surname>Jenoff</surname><given-names>JS</given-names></name><name name-style="western"><surname>Weinstein</surname><given-names>MS</given-names></name></person-group>. <article-title>Occult pulmonary arteriovenous malformation resulting in acute mesenteric ischemia and post-operative respiratory failure</article-title>. <source>Am Surg</source>. (<year>2011</year>) <volume>77</volume>:<fpage>1096</fpage>&#8211;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1177/000313481107700837</pub-id>, PMID: <pub-id pub-id-type="pmid">21944533</pub-id></mixed-citation></ref><ref id="ref97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>N</given-names></name><name name-style="western"><surname>Huang</surname><given-names>N</given-names></name><name name-style="western"><surname>Clavijo</surname><given-names>LC</given-names></name></person-group>. <article-title>Evaluation of percutaneous transcatheter embolization for pulmonary arteriovenous malformations</article-title>. <source>BMC Pulm Med</source>. (<year>2021</year>) <volume>21</volume>:<fpage>77</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12890-021-01448-z</pub-id><pub-id pub-id-type="pmid">33663424</pub-id><pub-id pub-id-type="pmcid">PMC7934521</pub-id></mixed-citation></ref><ref id="ref98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takao</surname><given-names>S</given-names></name><name name-style="western"><surname>Masuda</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Sakamoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Matsushima</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Pulmonary arteriovenous malformation exhibiting recanalization &gt;10 years after coil embolization: two case reports</article-title>. <source>Medicine</source>. (<year>2020</year>) <volume>99</volume>:<fpage>e18694</fpage>. doi: <pub-id pub-id-type="doi">10.1097/MD.0000000000018694</pub-id>, PMID: <pub-id pub-id-type="pmid">31914070</pub-id><pub-id pub-id-type="pmcid">PMC6959888</pub-id></mixed-citation></ref><ref id="ref99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>PE</given-names></name><name name-style="western"><surname>Duvnjak</surname><given-names>S</given-names></name><name name-style="western"><surname>Gerke</surname><given-names>O</given-names></name><name name-style="western"><surname>Kjeldsen</surname><given-names>AD</given-names></name></person-group>. <article-title>Long-term single-center retrospective follow-up after embolization of pulmonary arteriovenous malformations treated over a 20-year period: frequency of re-canalization with various embolization materials and clinical outcome</article-title>. <source>Cardiovasc Intervent Radiol</source>. (<year>2019</year>) <volume>42</volume>:<fpage>1102</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00270-019-02204-x</pub-id>, PMID: <pub-id pub-id-type="pmid">30887104</pub-id></mixed-citation></ref><ref id="ref100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woodward</surname><given-names>CS</given-names></name><name name-style="western"><surname>Pyeritz</surname><given-names>RE</given-names></name><name name-style="western"><surname>Chittams</surname><given-names>JL</given-names></name><name name-style="western"><surname>Trerotola</surname><given-names>SO</given-names></name></person-group>. <article-title>Treated pulmonary arteriovenous malformations: patterns of persistence and associated retreatment success</article-title>. <source>Radiology</source>. (<year>2013</year>) <volume>269</volume>:<fpage>919</fpage>&#8211;<lpage>26</lpage>. doi: <pub-id pub-id-type="doi">10.1148/radiol.13122153</pub-id>, PMID: <pub-id pub-id-type="pmid">23912618</pub-id></mixed-citation></ref><ref id="ref101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dinkel</surname><given-names>HP</given-names></name><name name-style="western"><surname>Triller</surname><given-names>J</given-names></name></person-group>. <article-title>Pulmonary arteriovenous malformations: embolotherapy with superselective coaxial catheter placement and filling of venous sac with Guglielmi detachable coils</article-title>. <source>Radiology</source>. (<year>2002</year>) <volume>223</volume>:<fpage>709</fpage>&#8211;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1148/radiol.2233010953</pub-id>, PMID: <pub-id pub-id-type="pmid">12034939</pub-id></mixed-citation></ref><ref id="ref102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayashi</surname><given-names>S</given-names></name><name name-style="western"><surname>Baba</surname><given-names>Y</given-names></name><name name-style="western"><surname>Senokuchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakajo</surname><given-names>M</given-names></name></person-group>. <article-title>Efficacy of venous sac embolization for pulmonary arteriovenous malformations: comparison with feeding artery embolization</article-title>. <source>J Vasc Interv Radiol</source>. (<year>2012</year>) <volume>23</volume>:<fpage>1566</fpage>&#8211;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvir.2012.09.008</pub-id>, PMID: <pub-id pub-id-type="pmid">23177103</pub-id></mixed-citation></ref><ref id="ref103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reichert</surname><given-names>M</given-names></name><name name-style="western"><surname>Kerber</surname><given-names>S</given-names></name><name name-style="western"><surname>Alkoudmani</surname><given-names>I</given-names></name><name name-style="western"><surname>Bodner</surname><given-names>J</given-names></name></person-group>. <article-title>Management of a solitary pulmonary arteriovenous malformation by video-assisted thoracoscopic surgery and anatomic lingula resection: video and review</article-title>. <source>Surg Endosc</source>. (<year>2016</year>) <volume>30</volume>:<fpage>1667</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00464-015-4337-0</pub-id>, PMID: <pub-id pub-id-type="pmid">26156615</pub-id></mixed-citation></ref><ref id="ref104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yap</surname><given-names>CW</given-names></name><name name-style="western"><surname>Wee</surname><given-names>BBK</given-names></name><name name-style="western"><surname>Yee</surname><given-names>SY</given-names></name><name name-style="western"><surname>Tiong</surname><given-names>V</given-names></name><name name-style="western"><surname>Chua</surname><given-names>YX</given-names></name><name name-style="western"><surname>Teo</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>The role of interventional radiology in the diagnosis and treatment of pulmonary arteriovenous malformations</article-title>. <source>J Clin Med</source>. (<year>2022</year>) <volume>11</volume>:<fpage>6282</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm11216282</pub-id>, PMID: <pub-id pub-id-type="pmid">36362510</pub-id><pub-id pub-id-type="pmcid">PMC9655058</pub-id></mixed-citation></ref><ref id="ref105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagano</surname><given-names>M</given-names></name><name name-style="western"><surname>Ichinose</surname><given-names>J</given-names></name><name name-style="western"><surname>Sasabuchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nakajima</surname><given-names>J</given-names></name><name name-style="western"><surname>Yasunaga</surname><given-names>H</given-names></name></person-group>. <article-title>Surgery versus percutaneous transcatheter embolization for pulmonary arteriovenous malformation: analysis of a national inpatient database in Japan</article-title>. <source>J Thorac Cardiovasc Surg</source>. (<year>2017</year>) <volume>154</volume>:<fpage>1137</fpage>&#8211;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jtcvs.2017.04.069</pub-id>, PMID: <pub-id pub-id-type="pmid">28629839</pub-id></mixed-citation></ref><ref id="ref106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Irie</surname><given-names>T</given-names></name><name name-style="western"><surname>Ishibashi</surname><given-names>O</given-names></name><name name-style="western"><surname>Kuramochi</surname><given-names>M</given-names></name><name name-style="western"><surname>Ichimura</surname><given-names>H</given-names></name><name name-style="western"><surname>Endo</surname><given-names>K</given-names></name></person-group>. <article-title>Retrospective single-arm cohort study of video-assisted thoracic surgery for treatment of idiopathic peripherally located simple type pulmonary arteriovenous malformation in 23 consecutive patients</article-title>. <source>J Cardiothorac Surg</source>. (<year>2023</year>) <volume>18</volume>:<fpage>213</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13019-023-02335-w</pub-id>, PMID: <pub-id pub-id-type="pmid">37403112</pub-id><pub-id pub-id-type="pmcid">PMC10318772</pub-id></mixed-citation></ref><ref id="ref107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Hao</surname><given-names>P</given-names></name><name name-style="western"><surname>Lv</surname><given-names>X</given-names></name><name name-style="western"><surname>Tian</surname><given-names>H</given-names></name></person-group>. <article-title>Treatment of a rare recurrent pulmonary arteriovenous malformation after multiple embolization by robotic-assisted thoracoscopic surgery</article-title>. <source>J Surg Case Rep</source>. (<year>2022</year>) <volume>2022</volume>:<fpage>rjac006</fpage>. doi: <pub-id pub-id-type="doi">10.1093/jscr/rjac006</pub-id><pub-id pub-id-type="pmid">35145623</pub-id><pub-id pub-id-type="pmcid">PMC8824442</pub-id></mixed-citation></ref><ref id="ref108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Duan</surname><given-names>L</given-names></name><name name-style="western"><surname>Mu</surname><given-names>S</given-names></name><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Cao</surname><given-names>D</given-names></name></person-group>. <article-title>Massive hemothorax induced by pulmonary arteriovenous malformation rupture: a case report and literature review</article-title>. <source>J Cardiothorac Surg</source>. (<year>2024</year>) <volume>19</volume>:<fpage>342</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13019-024-02867-9</pub-id><pub-id pub-id-type="pmid">38907280</pub-id><pub-id pub-id-type="pmcid">PMC11191350</pub-id></mixed-citation></ref><ref id="ref109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Majumdar</surname><given-names>S</given-names></name><name name-style="western"><surname>McWilliams</surname><given-names>JP</given-names></name></person-group>. <article-title>Approach to pulmonary arteriovenous malformations: a comprehensive update</article-title>. <source>J Clin Med</source>. (<year>2020</year>) <volume>9</volume>:<fpage>1927</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm9061927</pub-id><pub-id pub-id-type="pmid">32575535</pub-id><pub-id pub-id-type="pmcid">PMC7356967</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>